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ABSTRACT
This dissertation focuses on analog synthesis for biological evaluation and visible light
promoted method development. Chapter 1 centers upon the synthesis of Caenorhabditis elegans
dauer pheromone analogs. C. elegans is a nematode which, in times of environmental stress,
enters a dauer stage. Two highly conserved pathways, which play important roles in some
diseases in higher organisms, monitor dauer formation: TGF-β and IGF-1. Dauer formation is
triggered by the nematode’s chemosensation of the dauer pheromone, consisting of a group of
previously-isolated ascarosides. These compounds differ in chain length, saturation, terminal
functionality of side chain, ω vs. ω-1 oxygenation and presence of an indole-3-carboxyl
protecting group. The roles that these various functionalities play in dauer formation are poorly
understood. Therefore, analogs containing these functionalities are targeted for synthesis and
biological evaluation in dauer formation assays to determine their structure-activity relationships.
Chapter 2 concentrates on the synthesis of the infective juvenile (IJ) hormone of
Heterorhabditis bacteriophora. This nematode exists in the soil as a robust infective juvenile, a
“non-aging” and nonfeeding stage, homologous to the dauer stage of C. elegans. The hormone
responsible for IJ formation and accumulation is isolated via bioassay-guided fractionation. This
hormone’s structure is then elucidated, synthesized and evaluated for IJ formation activity.
In Chapter 3 of this dissertation, a new method for seleno- and tellurofunctionalization is
demonstrated. Selenocyclization has proven to be invaluable in the synthesis of complex natural
products. However, it often involves the use of PhSeX (X = Br or Cl), which is a class of watersensitive and toxic compounds. As a result, a visible light-promoted method is developed in
which PhSeBr is generated in situ from the reaction of Ph2Se2 and CBr4, as determined by 77Se

xiv

NMR. Selenofunctionalizations using this novel method with an array of substrates, including
the total synthesis of Amaryllidaceae alkaloid, γ-lycorane, is accomplished in excellent yields.
Chapter 4 describes the formation of an organic thin film using photocatalysis and aryl
iodides. Most commonly, organic thin films are generated using thiol precursors. However,
these thin films are often unstable to oxidation and thermal desorption. To circumvent these
issues, a visible light photocatalytic method is developed where aryl radicals generated from aryl
iodides are grafted to gold surfaces. The resulting thin films are extremely stable, due to the
strength of the covalent carbon-gold bond. The multilayers were characterized using atomic
force microscopy (AFM), X-ray photoelectron spectroscopy (XPS) and water contact angle
measurements.
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CHAPTER 1: SYNTHESIS AND BIOLOGICAL EVALUATION OF ASCAROSIDE
ANALOGS FOR BETTER UNDERSTANDING OF DAUER FORMATION IN
CAENORHABDITIS ELEGANS
1.1

Introduction
Sydney Brenner pioneered the use of C. elegans as a model organism for biological study

and won the Nobel Prize in 2002 for his efforts.1 C. elegans is a soil-dwelling nematode of 1
mm length as an adult, whose transparency allows researchers to study every cell and many
biological processes in action under a microscope.2 It is an unsegmented roundworm, consisting
of two tubes, an inner and an outer, and a pseudocoelom, which lies between the two. 3 The
pseudocoelom serves as both an immune and circulatory system and facilitates intracellular
signaling and nutrient dispersal.3-4 The outer tube is comprised of the cuticle and its underlying
hypodermis, excretory system, nervous system and muscles. The inner tube consists of the
reproductive and the alimentary systems.
C. elegans serves as an excellent model organism for many reasons. The worm is widely
used in part because of its short generation time and ease of manipulation in the laboratory. It is
also relatively inexpensive, and it has an average lifespan of 17 days, provided that food is
readily available and the temperature is held at 20°C.5 The nematodes are of small size, both
physically and genetically. Adult hermaphrodites have only 959 somatic cells and a genome size
of only 100 Mb. In a laboratory environment, they can be easily grown on a diet of bacteria
(usually E. coli) on agar plates or in a liquid medium. The diet of C. elegans in the wild is still
under speculation.6 It has been proposed that it feeds off of decaying organic matter, perhaps
necromenically from the corpse of its host.
Despite the relative simplicity of its physiology, C. elegans exhibits higher behavioral
processes such as response to sensory cues, learning and memory.3,
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The nematode also has

nearly as many genes as humans (20,000 in C. elegans versus 23,000 in humans).5 Scientists
have determined that 60-80% of C. elegans’ genes are homologous to those of humans.8
1.1.1 Life Cycle

Figure 1.1 Life cycle of C. elegans (Adapted from Wormatlas)
The life cycle of C. elegans is similar to that of other nematodes (Figure 1.1).3 The
normal cycle starts with embryogenesis in the hermaphrodite uterus and then moves through the
reproductive stages (L1-L4) to adulthood. The adult worm has an average lifespan of 2-3 weeks.
However, if exposed to harsh conditions – insufficient food supply, high population density, or
non-ideal temperature – C. elegans in the L1 larval stage can respond to chemical cues and enter
the non-aging dauer phase.9 In this stage, the nematode exhibits interesting behavioral and
developmental traits. While in this dauer phase, C. elegans experiences increased longevity and
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can live up to 4 months, approximately 5 times longer than the normal lifespan of the worm. The
morphology of C. elegans is also modified in the dauer stage. For example, the worm develops a
specialized tough cuticle that protects the dauer larva from environmental pressures.10 It can also
exhibit behavioral changes such as the cessation of feeding and relative immobility. When
conditions once again become favorable, the nematode senses environmental chemical cues and
can exit from the dauer stage to the L4 larva stage and continue on to adulthood.
1.1.2 The Dauer Pheromone
The dauer stage of C. elegans has become of increasing interest to the scientific
community.

This is due, in part, to the conservation of biological pathways between the

nematode and higher organisms. Two highly conserved pathways regulate dauer formation in C.
elegans: transforming growth factor beta (TGF-β) and insulin-like growth factor 1 (IGF-1).11 In
higher organisms, these pathways play an integral role in metabolism, aging and development as
well as some diseases like Alzheimer’s.12 The study of these pathways in high organisms can
often be difficult due to monetary, ethical or technical issues. Because C. elegans is easily
manipulated, grown and observed in a laboratory setting, it is an ideal candidate for the study of
these pathways. Studying these pathways in C. elegans may lead to therapeutics for human
diseases.
Dauer formation is triggered by C. elegans’ chemosensation of the “dauer pheromone,” a
secreted combination of ascarosides that are produced by the worm.13

The ascaroside

components of the dauer pheromone can be seen in Figure 1.2. The dauer pheromone includes
five compounds: asc-C6-MK,12 asc-C9,12 asc-C3,14 IC-asc-C515 and asc-C7-PABA16. The
first four compounds were isolated using bioassay-guided fractionation of extracts from high
volume worm cultures, and the structure was elucidated using NMR spectroscopy and mass
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spectrometry. These compounds demonstrate activity for dauer formation in the nM range and
have EC50 values corresponding to 120 nM, 370 nM, 240 nM and 5 nM. EC50 values represent
the concentration at which 50% dauer formation is observed. The last ascaroside was discovered
after comparative metabolomics studies and NMR spectroscopy.

The most potent of the

compounds is IC-asc-C5, with an EC50 value of 5 nM. However, this ascaroside is only
effective up to a certain concentration. At high concentrations, it inhibits its own activity, and
the percent dauer formation decreases drastically. One of the ascarosides, asc-C3, works
synergistally with some of the other dauer pheromone components, asc-C9, asc-C6-MK, and
IC-asc-C5, to induce dauer formation.14 Asc-C3 is also the only compound of the dauer
pheromone that is oxygenated at the  position of the fatty side chain.
O
CO2H

O

HO

O

O

O
O

HO

OH
asc--C3
EC50 = 240 nM
CO2H
O

CO2H
O
O
HN

O

O

O
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OH
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O

N
H

O

HO

OH
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EC50 = 5 nM

OH

asc-C7-PABA

Figure 1.2 Ascarosides in the dauer pheromone
All of the ascarosides that compose the dauer pheromone adhere to a set of structural
guidelines. The backbone of each compound is the ascarylose sugar moiety, seen in red in
Figure 1.3. This building block can be functionalized in several ways. Firstly, there can be
several head groups, of which the unprotected alcohol and the indole-3-carbonyl (IC) are the
4

most common. The fatty acid side chain can also be modified to include the presence of an
alkene or an R group. When R = H, the compound is termed an -ascaroside. However, when
R=Me, the compound is defined as an (-1)-ascaroside. The terminus of the side chain, seen in
pink, may also be functionalized to include a simple carboxylic acid, methyl ketone (MK), or a
para-aminobenzoic acid (PABA) group. As can be observed in Figure 1.2, small changes in
structure can alter the dauer formation activity of the ascaroside.
Head group

Ascarylose

Side chain

Terminus group
H
N

PABA

R
n

O
O
IC

N
H

CO2H

O

O

Asc

CH3

O

MK

OH

Figure 1.3 General structure of dauer ascarosides
As previously stated, C. elegans enters the dauer stage via chemosensation of the dauer
pheromone. The dauer pheromone is secreted into the environment by the worm as a way to
gather information about the population density in its immediate vicinity.17 As a result, the
greater the number of nematodes present at any given time, the higher the concentration of the
dauer pheromone. The dauer pheromone promotes dauer formation and prevents recovery to its
normal life cycle. In direct competition with the dauer pheromone is an, as yet, unknown “food
signal,” which can give information about food availability in the environment. Whether C.
elegans will enter the dauer stage and continue to stay in this stage of arrested development relies
heavily upon the balance between these two chemical cues, the dauer pheromone and the “food
signal.”13
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The dauer pheromone is sensed by C.elegans using G protein-coupled receptors
(GPCRs). Hundreds of GPCRs are expressed by chemosensory neurons located on the head of
the worm.18 Binding of the ascarosides by the GPCRs on the neurons and the resulting dauer
formation was discovered through various experimental methods. For example, when two alpha
subunits of GPCRs, gpa-2 and gpa-3, were upregulated, dauer formation was induced.19 When
the same subunits were mutated, no dauer formation was observed. The main neurons associated
with GPCR expression in C.elegans are ADF, ASG, ASI, ASJ and ASK. These neurons are
responsible for the chemosensation of the dauer pheromone. The ASI and ASJ neurons are
particularly important, because they regulate the IGF-1 and TGF- pathways.20 When the dauer
pheromone is detected, the neurons will downregulate the production of secondary messengers
like TGF- and insulin-like peptides.20b The IGF-1 and TGF- pathways, as a result, are
downregulated. As previously mentioned, the IGF-1 pathway is highly conserved throughout
nature, remaining relatively unchanged from C. elegans to higher organisms, like humans. The
IGF-1, in particular, plays an important role in the aging process. For example, when DAF-2, C.
elegans’s sole IGF-1 receptor, is mutated, the worm’s lifespan is doubled.21 Mutations of genes
related to the IGF-1 pathway in other, more complex organisms like Drosphila melanogaster and
mice has also led to deceleration of the aging process.22 IGF-1 is also associated with cancer. In
studies where there is a presence of decreased IGF levels, the growth of existing cancer cells is
also decreased.23

Additionally, diets that have been demonstrated to downregulate IGF-1

pathways are also associated with a lower cancer risk.24
The TGF- pathway is also highly conserved between C. elegans and humans. This
pathway is associated with various diseases as well. Studies have shown that TGF- plays
different roles in cancer promotion and metastasis.
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Interestingly, the role can change

dramatically between the various types of cancer.25 For example, in gastric and pancreatic
cancers, the TGF- pathway is effectively shut down. However, the opposite is true for breast
and skin cancer. In these types of cancer, the TGF- pathway is actually shown to be associated
with tumor progression and is upregulated in some cases.

This pathway, therefore, has a

complex relationship with cancer and can act as both a cancer promoter and suppressor. In
addition to cancer, there is also a correlation between the TGF- pathway and Alzheimer’s
disease.

The blood and cerebral fluid of human patients with the disease exhibit higher

concentrations of TGF-.26 Therefore, the study of these two pathways is of great importance in
order get a better insight in the hopes of finding therapeutic treatments or even cures for various
diseases.
1.1.3 Biosynthesis of Dauer Ascarosides
The biosynthesis of the dauer pheromone ascarosides inside of the worm has been the
subject of many studies, but many questions still remain. Less is known about the initial steps in
the biosynthesis of the dauer pheromone ascarosides. However, it is suspected that the first step
in the biosynthesis is the chain elongation of fatty acids (Scheme 1.1).27

This could be

accomplished using chain elongase homolog elo 1-9, which has been demonstrated to perform
this function in other signaling pathways.28 After elongation, the newly formed very long chain
fatty acids (VLCFA’s) would undergo oxygenation at either the  or -1 position and then
glycosylation with 3,6-dideoxysugar ascarylose.27 The oxygenated very long chain ascarosides
(VLCA’s) then enter the peroxisomal -oxidation cascade, which consists of the enzymes acox1, maoc-1, dhs-28 and daf-22.

It is also possible that ascarylose addition occurs after -

oxidation. However,  or -1 oxygenation is thought to occur prior to oxidation due to an
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experiment which determined that the acox-1 mutant affects  and -1 oxygenated asarosides in
different ways.
After glycosylation, the VLCA’s enter the peroxisomal -oxidation pathway, as seen in
Scheme 1.1.27 The first step of peroxisomal -oxidation is the introduction of the alkene at the
, position. This is accomplished using the enzyme, acyl-CoA oxidase ACOX-1. The next
step involved the hydration of the alkene using enoyl-CoA hydratase (MAOC-1).

After

hydration, the alcohol is oxidized to the ketone with (3R)-hydroxyacyl-CoA dehydrogenase
(DHS-28). In higher organisms like some vertebrates and Drosphila melanogaster, these two
steps (hydration and oxidation) are combined, and the transformation is performed by one
protein, e.g. MFE-2. The last step in the peroxisomal -oxidation pathway is the cleavage of the
diketone intermediate by β-ketoacyl-CoA thiolase DAF-22.

Usually, this entire process

continues until the chain is between 6 and 12 carbons in length.29 The indole group is added last,
but the mechanism of addition is not known. However, this step is known to be highly specific.
chain elongation
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Scheme 1.1 Biosynthetic pathway for dauer pheromone ascarosides
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Although the biosynthesis of ascarylose in bacteria is well understood, less is known
about the biosynthesis of ascarylose in C. elegans. Studies that demonstrated the presence of
ascarosides in axenic cultures of C. elegans point to the endogenous synthesis of ascarylose.30
Additionally, the C. elegans genome contains many homologs to genes that are a part of the
synthetic pathway of ascarylose in bacteria, which deserves further investigation.
1.2

Results and Discussion

1.2.1 Synthesis of Ascaroside Analogs
The ascarosides that comprised the dauer pheromone are similar in many ways. For
example, all contain the ascarylose backbone, with the anomeric carbon being in the 
configuration.

The majority of the pheromone components also have free alcohols. Despite

these similarities, the molecules differ greatly in terminal functional groups (carboxylic acid,
ketone, and amide), chain length, saturation and indolyl carboxyl protection of one of the free
alcohols. In an effort to determine structure-activity relationships of the various functional
groups present in the dauer pheromone ascarosides and to potentially discover a new ascaroside
with high dauer-formation activity, multiple analogs were synthesized and biologically evaluated
using dauer formation assays.31 The synthesized analogs containing various functionalities were
used to determine structure-activity relationships for side chain attributes and their dauerinducing ability.
The analogs targeted for synthesis and biological evaluation contained a wide variety of
moieties. The analogs synthesized by this researcher, ascarosides in the OH/MK series, differed
in side-chain length and terminal functionality (alcohol vs. methyl ketone), as is demonstrated by
the boxed region of Figure 1.4. The first step towards the synthesis of the selected analogs was
glycosylation using dibenzoyl ascarylose 3 as glyocsyl donor and alcohols 1 and 2 as glycosyl
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acceptors (Scheme 1.2).32 Dibenzoyl ascarylose was previously synthesized according to a
known procedure.
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Figure 1.4 Targeted ascaroside analogs
BF3 etherate, which coordinated to the anomeric alcohol of dibenzoyl ascarylose 3, was
used as a Lewis acid, rendering it a better leaving group. Sugars 4 and 5 were produced solely in
the β configuration due to neighboring group participation from the adjacent benzoyl protecting
groups. This phenomenon is shown in Scheme 1.2. After the lone pair from the ring oxygen
donates into the * orbital of the anomeric carbon-oxygen bond, promoting the loss of the
alcohol, an oxonium intermediate is formed. The electron lone pair on the carbonyl oxygen on
the benzoyl protecting group adjacent to the anomeric carbon attacks, effectively blocking the
bottom face from addition of alcohols 1 or 2. Using this method, glycosylation products 4 and 5
were successfully synthesized in 73% and 90%, respectively, in a short amount of time.
Originally, reagent grade DCM was used, but dry DCM from a solvent system increased the
glycosylation yields significantly. For example, glycosylation using alcohol 2 and dry DCM
increased yields from 70% to 90%.
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Scheme 1.2 Glycosylation with ascarylose via neighboring group participation
Next in the synthesis of the desired ascaroside analogs, olefin cross metathesis was
performed using Grubbs 2nd generation ruthenium catalyst.33 This catalyst was used as opposed
to the Grubbs 1st generation catalyst due to its comparatively higher reactivity. Cross metathesis
under these conditions gave alkenes 6-8 as a mixture of E and Z isomers. The mixture of E/Z
isomers, however, did not pose any concern as the next step in the synthesis would negate any
stereochemistry.

Using 3 equivalents of Grubbs 2nd generation catalyst, ascaroside 5 was

converted into the desired metathesis product 8 in a modest yield of 57%. In order to optimize
this reaction, varying equivalents of alcohol were used (Scheme 1.3).

Out of 3 and 10

equivalents, the reaction using 10 equivalents of alcohol provided the best yield of 93%.
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Scheme 1.3 Optimization of cross metathesis
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After optimizing the reaction conditions, alcohol 1 was submitted to cross metathesis
with the ascaroside 4, and alcohol 2 was paired with ascaroside 4 (Scheme 1.4). Both reactions
proceeded successfully, giving the 8 carbon chain alcohol 6 and 9 carbon chain alcohol 7 in 75%
and 79% yields, respectively. Purification of all cross metathesis products was completed
readily via column chromatography.
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Scheme 1.4 Cross metathesis producing analogs with varying chain lengths
The next step in the synthesis of the ascaroside analogs was the hydrogenation of the
alkene in the side chain to produce the saturated sugars 9-11.

This transformation was

accomplished using 1atm H2 (balloon) and 10% palladium on activated carbon. Purification
proved to be simple, consisting only of filtration through a short Celite® plug. Yields were
excellent, ranging from 94%-99% for saturated analogs 9-11 (Scheme 1.5).
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Scheme 1.5 Hydrogenation and oxidation of ascarosides
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To streamline the synthesis and possibly increase yields, a one-pot, ruthenium-catalyzed
cross metathesis/hydrogenation reaction was attempted according to the procedure provided by
Grubbs.34 This reaction, however, was messy, producing many side products, and did not yield
any desired hydrogenation product. Some of the material 9-11 was then oxidized to the ketone
via reaction with PCC in DCM. The desired ketones 12-14 were obtained in near quantitative
yields (96%-99%).
The desired asc-OH analogs were synthesized directly from 9-11 via deprotection using
hydrolysis or methanolysis (Scheme 1.6). Deprotection was initially performed using potassium
carbonate and methanol as solvent, and flash chromatography was used to purify the product.
However, this method gave the product in low yields (13%-31%). Difficulties in purification
were due to the hydrolyzed product having a similar polarity to the methyl benzoate by-product.
In an effort to obtain better separation, HPLC was used to purify the methanolysis products.
This method, although providing better yields overall (44% for asc-C8-OH), did not completely
separate the desired product from the impurities.

In addition to purification issues, the

methanolysis reaction itself was problematic, as demonstrated by messy crude 1H NMR’s.
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In an attempt to provide a more basic environment which would increase reactivity of the
system, 1M LiOH was used with methanol as solvent. This method was determined to be a
much better method when coupled with purification via HPLC, improving yields dramatically.
Yields of hydrolysis for asc-C9-OH and asc-C10-OH were increased to 89% and 94%,
respectively. Hydrolysis using 1M LiOH and methanol was also successful for the asc-MK
series, giving yields ranging from 77%-84%. Hydrolysis conditions were also attempted for the
formation of asc-C8-OH. Purification of this reaction was difficult due to the similar polarities
of the desired product and impurities. Therefore, for this transformation, methanolysis was
considered the better synthetic route.
1.2.2 Biological Evaluation of Ascaroside Analogs
After synthesizing all of the ascaroside analogs, the research lab of Rebecca Butcher at
University of Florida performed biological evaluations to determine the activity of each
synthesized compound in promoting dauer formation.31 These determinations were made by
performing dauer formation assays.

In these assays, the synthesized ascarosides at two

concentrations, 220 nM and 6000 nM, were mixed with nematode growth media (NGM) agar
and heat-killed E. coli, poured into plates and allowed to set. The concentrations of synthesized
ascarosides were chosen for specific reasons. The lower concentration, 220 nM, was used
because it is in the range of the EC50 values for the dauer pheromone components. The higher
concentration, 6000 nM, was chosen because any activity towards dauer formation would be
observable at this concentration. The C.elegans nematodes were then allowed to lay eggs on the
media and incubated for 68-72 hrs at 25C. After the allotted incubation time, plates containing
50-100 worms were collected for analysis and dauers were recognized by small size and lack of
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pharyngeal pumping. The percentage of dauers over the total population of worms in each
experiment was then determined.
The activities of all of the synthesized compounds were compared to those of the
ascarosides that comprise the dauer pheromone. The assay was performed at two concentrations,
220 nM and 6000 nM. Overall, the activities of each of the compounds were low compared to
those of the known dauer pheromone ascarosides. There was a direct correlation present in chain
length versus percent dauer formation. As the chain length increased, the activity towards dauer
formation also increased. The most active of the OH/MK series consisted of a ten carbon side
chain. The asc-C10-MK analog was slightly more active than the asc-C10-OH ascaroside. In
general, the MK series was more active for dauer formation than the OH series. Predictably, the
high concentration for almost all of the ascarosides led to a higher percent of dauer formation.
However, in nature, the dauer pheromone is never present at either concentration.
Table 1.1 Activity of dauer pheromone components and synthesized ascarosides
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None of the synthesized ascarosides exhibited activities near those of the known dauer
pheromone components even though many only differed by one carbon or one functional group.
For example, asc-C8-MK only differs from the naturally-occurring asc-c6-MK by two carbons.
However, the percent dauer formation for the unnatural ascaroside was drastically lower than
that of the dauer pheromone component, especially at the lower concentration. The performed
biological studies indicate that the activity in promoting dauer formation is highly dependent on
the structure of the ascarosides.

The synthesized ascarosides and the dauer pheromone

components are largely similar, containing an ascarylose moiety, and only differing in structural
attributes like chain length, terminal functionality and degree of unsaturation. Yet all of the
ascarosides exhibited drastically different activities. These results led to the conclusion that the
G-coupled protein receptors that bind their respective cognate ascarosides are highly selective.
Evolutionarily speaking, this selectivity could be due to the need to prohibit “cross talk” between
similar species in the same environment. For example, C.elegans and C.briggsae occupy the
same general environment and both use ascarosides for signaling purposes.35 Each worm would
need to have its own means of receiving chemical cues without interference from the other
species.
1.3

Conclusions
In conclusion, multiple analogs containing varying functionalities were synthesized in

order to determine structure-activity relationships for side chain structural attributes and their
dauer-inducing ability.

The synthesized analogs differed in chain length and terminal

functionality oxidation state, both alcohol and ketone. The general scheme for synthesizing the
ascarosides began with the benzoyl ascarylose backbone. The glycosylation of this building
block with various alkenols yielded the intermediates 4 and 5 in excellent yields, especially after
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using dry solvents.

The glyosylation products then underwent cross metathesis with other

alkenols 6-8 using Grubbs 2nd generation catalyst. Interestingly, a mixture of E/Z isomers was
produced. This lack of stereoselectivity was not a concern, however, because the next step was
hydrogenation of the alkene to give the saturated ascarosides 9-11.

Ketones 12-14 were

synthesized from the alcohol via oxidation by PCC. Lastly, the benzoate groups on the OH-MK
series were removed using either methanolysis or hydrolysis to yield the desired ascaroside
analogs.
Once synthesized, the ascaroside analogs were then analyzed in biological assays by
collaborators at University of Florida to determine each compound’s activity towards dauer
formation in C. elegans. However, none of the analogs exhibited any relevant activity in the
dauer formation, despite structural similarities between these analogs and the dauer pheromone
components. This evidence points to the G protein-coupled receptors’ high selectivity towards
binding of their cognate ascarosides. The lack of promiscuity in receptor binding may have
developed over time as a need to prevent “cross-talk” between various species, which occupy the
same environment and use ascarosides for chemical signaling.
1.4

Experimental

1.4.1 General Methods
Flash column chromatography was performed using 60 Å silica gel. 1H NMR and 13C
NMR spectroscopy were performed on a Bruker AV-400, DPX 400, DPX 250 or Varian 500
spectrometer. HPLC purifications were conducted with a Waters Breeze 2 system equipped with
an XBridge C18 semi-preparative column (5 lm, 10 x 100 mm) with gradient runs of H2O in
CH3CN. Mass spectra were obtained using an Agilent 6210 electrospray time-of-flight mass
spectrometer. Optical rotation measurements were obtained using a JASCO P-2000 polarimeter.
Unless otherwise noted, all materials were obtained from commercial suppliers and used without
17

further purification. Analytical TLC was conducted on aluminum sheets (Merck, silica gel 60,
F254). Compounds were visualized by UV absorption (254 nm) and staining with anisaldehyde
or KMnO4. All glassware (save for hydrolysis reactions) was flame-dried under vacuum and
backfilled with dry nitrogen prior to use. Deuterated solvents were obtained from Cambridge
Isotope Labs. All solvents were purifies according to the method of Grubbs.36
1.4.2 Procedures and Characterization
Representative procedure for glycosylation – synthesis of 5:
A suspension of 1.0228 g (2.8701 mmol) dibenzoylascarylose 3, 0.54 mL (4.5 mmol)
alcohol 2 and 325.8 mg 4Å molecular sieves in 32 mL CH2Cl2 was cooled to 0oC. To this
suspension was added 1.54 mL (12.2 mmol) BF3.OEt2 at once. The resulting suspension was
stirred at 0oC for 7 h. 30 mL saturated NaHCO3 solution was then added. Upon cessation of
effervescence, the aqueous layer was separated from the organic layer and then extracted with
3x20mL CH2Cl2. The resulting organic extracts were dried over MgSO4 and filtered to obtain
1.5492 mg of oil after evaporation of solvent. Silica gel column chromatography (35 g silica gel,
gradient run from 50% hexanes in CH2Cl2 to 30% hexanes in CH2Cl2) afforded 1.1364 g (90%)
of a colorless syrup.

[α]D25 = -15.0, c 1.74 (CH2Cl2); HRMS (m/z): [M+Na]+calcd. for

C26H30O6Na 461.1935, found 461.1946; 1H NMR (250 MHz, CDCl3): δ 8.13 (d, J = 7.0 Hz, 2H),
8.06 (d, J = 7.0 Hz, 2H), 7.56 (m, 2H), 7.45 (m, 4H), 5.89 (ddt, J = 16.8, 10.2, 6.5 Hz, 1H), 5.09
(m, 5H), 4.16 (dq, J = 9.8, 6.2 Hz, 1H), 3.89 (m, 1H), 2.45 (dt, J = 13.5, 4.0 Hz, 1H), 2.24 (m,
3H), 1.70 (m, 2H), 1.30 (d, J = 6.2 Hz, 3H), 1.22 (d, J = 6.1 Hz, 3H);
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C NMR (62.5 MHz,

CDCl3): δ 166.0; 165.9; 138.6; 133.43; 133.37; 130.2; 130.1; 129.8; 128.6; 115.0; 93.9; 72.2;
71.4; 70.8; 67.2; 36.5; 30.2; 29.9; 19.3; 18.1.
Synthesis of 4:
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Started with 1.027 g (2.884 mmol) dibenzoylascarylose 3, 0.46 mL (4.5 mmol) alcohol 1,
302.9 mg 4Å molecular sieves, and 1.54 mL (12.2 mmol) BF3.OEt2 in 30 mL CH2Cl2. Purified to
obtain 891.5 mg (73%) of a colorless oil. [α]D25 = -10.7, c 1.015 (CH2Cl2); HRMS (m/z):
[M+Na]+calcd. for C25H28O6Na 447.1778, found 447.1790; 1H NMR (250 MHz, CDCl3): δ 8.12
(d, J = 7.6 Hz, 2H), 8.05 (d, J = 7.9 Hz, 2H), 7.57 (m, 2H), 7.47 (m, 4H), 5.89 (ddt, J = 17.3,
10.3, 7.1 Hz, 1H), 5.16 (m, 4H), 4.96 (s, 1H), 4.15 (dq, J = 12.7, 6.2 Hz, 1H), 3.92 (m, 1H), 2.32
(m, 4H), 1.28 (d, J = 6.2 Hz, 3H), 1.21 (d, J = 6.0 Hz, 3H);
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C NMR (62.5 MHz, CDCl3): δ

165.8; 165.7; 135.0; 133.31; 133.25; 130.1; 129.9; 129.7; 128.5; 117.3; 94.0; 72.5; 71.3; 70.7;
70.0; 41.7; 29.8; 19.0; 17.9.
Representative procedure for cross metathesis – synthesis of 8:
To a solution of 18.8 mg (0.0429 mmol) alkene 5 and 52 µL (0.43 mmol) alcohol 2 in 1.3
mL CH2Cl2 at reflux was added 3.7 mg (0.0044 mmol) Grubbs 2nd generation ruthenium catalyst
at once. The resulting solution was allowed to stir at reflux for 1 h and allowed to cool to 25°C.
The reaction mixture was concentrated to 58.4 mg of brown oil. Silica gel column
chromatography (silica gel, gradient run from 10% ethyl acetate in hexanes to 30% ethyl acetate
in hexanes) afforded 20.4 mg (93%) of a yellow oil. [α]D25 = -23.7, c 0.76(CH2Cl2); HRMS
(m/z): [M+Na]+calcd. for C30H38O7Na 533.2510, found 533.2522; 1H NMR (250 MHz, CDCl3):
δ 8.12 (d, J = 7.2 Hz, 2H), 8.05 (d, J = 7.0 Hz, 2H), 7.59 (m, 2H), 7.47 (m, 4H), 5.53 (m, 2H),
5.16 (m, 2H), 4.96 (s, 1H), 4.12 (dq, J = 12.7, 6.2 Hz, 1H), 3.85 (m, 2H), 2.42 (dt, J = 13.4, 4.0
Hz, 1H), 2.21 (m, 5H), 1.55 (m, 5H), 1.28 (d, J = 6.2 Hz, 3H), 1.20 (m, 6H).
Synthesis of 6:
Started with 235.2 mg (0.5541 mmol) alkene 4, 0.57 mL (5.5 mmol) alcohol 1, and 47.0
mg (0.0553 mmol) Grubbs 2nd generation ruthenium catalyst in 17 mL CH2Cl2. Purified to obtain
223.6 mg (84%) of a yellow oil. [α]D25 = 24.5, c 0.965 (CH2Cl2); HRMS (m/z): [M+Na]+calcd.
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for C28H34O7Na 505.2197, found 505.2210; 1H NMR (250 MHz, CDCl3): δ 8.11 (d, J = 7.1 Hz,
2H), 8.05 (d, J = 7.0 Hz, 2H), 7.57 (m, 2H), 7.46 (m, 4H), 5.59 (m, 2H), 5.16 (m, 2H), 4.95 (s,
1H), 4.14 (dq, J = 9.9, 6.2 Hz, 1H), 3.86 (m, 2H), 2.27 (m, 6H), 1.28 (d, J = 6.2 Hz, 3H), 1.20 (d,
J =6.3 Hz, 3H), 1.19 (d, J = 6.1 Hz, 3H).
Synthesis of 7:
Started with 1.1364 g (2.5915 mmol) alkene 4, 2.67 mL (25.9 mmol) alcohol 2, and 220.1
mg (0.2589 mmol) Grubbs 2nd generation ruthenium catalyst in 80 mL CH2Cl2. Purified to obtain
1.0211 g (79%) of a yellow oil. [α]D25 = -6.446, c 11.47 (CH2Cl2); HRMS (m/z): [M+Na]+calcd.
for C29H36O7Na 519.2353, found 519.2356; 1H NMR (400 MHz, CDCl3): δ 8.10 (d, J = 7.4 Hz,
2H), 8.03 (d, J = 7.5 Hz, 2H), 7.54 (m, 2H), 7.43 (m, 4H), 5.53 (m, 2H), 5.18 (m, 2H), 4.95 (s,
1H), 4.13 (dq, J = 12.1, 6.3 Hz, 1H), 3.83 (m, 2H), 2.42 (dt, J = 13.0, 4.1 Hz, 1H), 2.18 (m, 5H),
1.71 (m, 1H), 1.58 (m, 1H), 1.28 (d, J = 6.2 Hz, 3H), 1.19 (d, J = 6.1 Hz, 3H), 1.17 (d, J = 6.3
Hz, 3H).
Representative procedure for hydrogenation – synthesis of 11:
A suspension of 376.7 mg (0.7382 mmol) unsaturated alcohol 8 and 44.9 mg 10 %
palladium on activated carbon in 41 mL EtOAc was vacuum purged and back filled with H2 from
a balloon. The resulting suspension was allowed to stir at 23oC for 7 h. The reaction mixture was
filtered through Celite® and concentrated to obtain 375.4 mg (99%) of colorless oil that required
no further purification.[α]D25 = -36, c 0.12 (CH2Cl2); HRMS (m/z): [M+Na]+calcd. for
C30H40O7Na 535.2666, found 535.2654; 1H NMR (250 MHz, CDCl3): δ 8.11 (d, J = 7.7 Hz, 2H),
8.04 (d, J = 7.7 Hz, 2H), 7.59 (m, 2H), 7.47 (m, 4H), 5.18 (m, 2H), 4.95 (s, 1H), 4.12 (dq, J =
12.0, 6.1 Hz, 1H), 3.83 (m, 2H), 2.42 (dt, J = 13.6, 4.1 Hz, 1H), 2.19 (m, 1H), 1.46 (m, 13H),
1.28 (d, J = 6.2 Hz, 3H), 1.19 (d, J = 6.0 Hz, 6H); 13C NMR (100 MHz, CDCl3): δ 166.0; 165.9;
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133.43; 133.39; 130.2; 130.1; 129.8; 128.6; 94.0; 72.9; 71.5; 70.9; 68.3; 67.2; 39.6; 37.3; 29.9;
29.84; 29.77; 26.0; 25.9; 23.7; 19.4; 18.1.
Synthesis of 9:
Started with 168.7 mg (0.3496 mmol) unsaturated alcohol 6 and 25.8 mg 10 % palladium
on activated carbon in 23 mL EtOAc. Obtained 160.1 mg (95%) of a pure colorless oil without
further purification. [α]D25 = -27, c 0.18 (CH2Cl2); HRMS (m/z): [M+Na]+calcd. for C28H36O7Na
507.2353, found 507.2348; 1H NMR (400 MHz, CDCl3): δ 8.11 (m, 2H), 8.05 (m, 2H), 7.58 (m,
2H), 7.46 (td, J = 7.7, 3.5 Hz, 4H), 5.17 (m, 2H), 4.95 (s, 1H), 4.12 (dq, J = 9.8, 6.2 Hz, 1H),
3.85 (m, 2H), 2.42 (dt, J = 13.6, 4.0 Hz, 1H), 2.21 (ddd, J = 13.9, 11.4, 3.2 Hz, 1H), 1.50 (m,
8H), 1.28 (d, J = 6.2 Hz, 3H), 1.21 (d, J = 6.2 Hz, 3H); 1.19 (d, J = 6.2 Hz, 3H); 13C NMR (100
MHz, CDCl3): δ 166.0; 165.9; 133.5; 133.4; 130.2; 130.1; 129.8; 128.7; 94.0; 72.8; 71.5; 70.9;
68.3; 67.2; 39.5; 37.3; 29.9; 26.0 (2C); 23.8; 19.4; 18.1.
Synthesis of 10:
Started with 786.6 mg (1.584 mmol) unsaturated alcohol 7 and 94.2 mg 10 % palladium
on activated carbon in 88 mL EtOAc. Obtained 743.4 mg (94%) of a pure colorless oil without
further purification. [α]D25 = 7.04, c 1.81 (CH2Cl2); HRMS (m/z): [M+Na]+calcd. for
C29H38O7Na 521.2510, found 521.2506; 1H NMR (250 MHz, CDCl3) δ 8.11 (m, 2H), 8.04 (m,
2H), 7.58 (m, 2H), 7.42 (m, 4H), 5.18 (m, 2H), 4.95 (s, 1H), 4.12 (m, 1H), 3.84 (m, 2H), 2.42
(dt, J = 14.2, 3.9 Hz, 1H), 2.24 (m, 1H), 1.49 (d, J = 46.5 Hz, 10H), 1.28 (d, J = 6.3 Hz, 3H),
1.21 (d, J = 2.6 Hz, 3H), 1.18 (d, J = 2.5 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 166.0; 165.9;
133.41; 133.36; 130.2; 130.0; 129.8; 128.6; 94.0; 72.8; 71.4; 70.9; 68.3; 67.1; 39.5; 37.3; 29.9;
29.8; 25.9 (2C); 23.7; 19.3; 18.1.
Representative procedure for oxidation – synthesis of 12:
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To a suspension of 129.7 mg (0.6017 mmol) pyridinium chlorochromate and 111.2 mg
4Å molecular sieves in 21 mL CH2Cl2 at 0oC was added 72.2 mg (0.149 mmol) saturated alcohol
9 at once. The resulting suspension was allowed to stir 0oC for 2 h. The reaction mixture was
concentrated to 89.2 mg of dark red oil. Silica gel column chromatography (30.24 g silica gel,
gradient run from 7.5% diethyl ether in CH2Cl2 to 12% diethyl ether in CH2Cl2) afforded 71.3
mg (99%) of a colorless oil. [α]D25 = -66, c 0.065 (CH2Cl2); HRMS (m/z): [M+Na]+calcd. for
C28H34O7Na 505.2197, found 505.2181; 1H NMR (400 MHz, CDCl3) δ 8.11 (d, J = 7.7 Hz, 2H),
8.05 (d, J = 7.4 Hz, 2H), 7.57 (t, J = 7.5 Hz, 2H), 7.45 (m, 4H), 5.16 (m, 2H), 4.94 (s, 1H), 4.10
(dq, J = 12.3, 6.4 Hz, 1H), 3.83 (m, 1H), 2.47 (t, J = 7.4 Hz, 2H), 2.41 (dt, J = 13.7, 3.9 Hz, 1H),
2.21 (m, 1H), 2.15 (s, 3H), 1.56 (m, 6H), 1.28 (d, J = 6.3 Hz, 3H), 1.18 (d, J = 6.1 Hz, 3H);

13

C

NMR (100 MHz, CDCl3): δ 209.1; 166.0; 165.9; 133.5; 133.4; 130.2; 130.1; 129.8; 128.7; 94.0;
72.7; 71.4; 70.9; 67.2; 43.8; 37.1; 30.2; 29.9; 25.5; 24.0; 19.3; 18.1.
Synthesis of 13:
Started with 605.7 mg (2.810 mmol) pyridinium chlorochromate, 328.3 mg (0.6584
mmol) saturated alcohol 10, and 513.8 mg 4Å molecular sieves in 120 mL CH2Cl2. Purified to
obtain 313.6 mg (96%) of a colorless oil. [α]D25 = 3.33, c 3.83 (CH2Cl2); HRMS (m/z):
[M+Na]+calcd. for C29H36O7Na 519.2353, found 519.2363; 1H NMR (400 MHz, CDCl3): δ 8.11
(m, 2H), 8.05 (m, 2H), 7.58 (td, J = 7.3, 2.2 Hz, 2H), 7.46 (td, J = 7.4, 2.9 Hz, 4H), 5.16 (m, 2H),
4.95 (s, 1H), 4.11 (m, 1H), 3.84 (m, 1H), 2.44 (m, 3H), 2.15 (m, 4H), 1.50 (m, 8H), 1.29 (d, J =
6.1 Hz, 3H), 1.19 (d, J = 6.1 Hz, 3H);

13

C NMR (100 MHz, CDCl3): δ 209.2; 166.0; 165.9;

133.41; 133.37; 130.2; 130.0; 129.8; 128.6; 93.9; 72.7; 71.4; 70.8; 67.2; 43.9; 37.1; 30.1; 29.9;
29.4; 25.8; 23.9; 19.3; 18.1.
Synthesis of 14:
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Started with 123.4 mg (0.5725 mmol) pyridinium chlorochromate, 58.6 mg (0.114 mmol)
saturated alcohol 11, and 93.9 mg 4Å molecular sieves in 20 mL CH2Cl2. Purified to obtain 52.0
mg (89%) of a colorless oil. [α]D25 = 26.6, c 0.775 (CH2Cl2); HRMS (m/z): [M+Na]+calcd. for
C30H38O7Na 533.2510, found 533.2525; 1H NMR (250 MHz, CDCl3) δ 8.12 (d, J = 7.0 Hz, 2H),
8.05 (d, J = 7.1 Hz, 2H), 7.57 (m, 2H), 7.46 (m, 4H), 5.17 (m, 2H), 4.95 (s, 1H), 4.12 (dq, J =
12.6, 6.6 Hz, 1H), 3.84 (m, 1H), 2.43 (m, 3H), 2.14 (m, 4H), 1.54 (m, 10H), 1.29 (d, J = 6.2 Hz,
3H), 1.19 (d, J = 6.0 Hz, 3H);

13

C NMR (100 MHz, CDCl3): δ 209.0; 165.7; 165.6; 133.11;

133.07; 129.9; 129.7; 129.5; 128.3; 93.6; 72.5; 72.4; 71.1; 70.5; 66.8; 43.6; 36.9; 36.8; 29.7;
29.6; 29.3; 29.0; 25.5; 23.6; 19.2; 17.8.
Method A:
Representative procedure for methanolysis with K2CO3 – synthesis of asc-C8-OH:
To a suspension of 10.8 mg (0.0223 mmol) saturated alcohol 9 in 1.5 mL MeOH was
added 1.8 mg (0.013 mmol) K2CO3 at once. The resulting solution was allowed to stir at reflux
for 5 h and allowed to cool to 25°C. The reaction mixture was concentrated to 17.3 mg of
colorless oil. HPLC purification afforded 2.7 mg (44%) of a colorless oil. [α]D25 = -22, c 0.14
(CH3OH); HRMS (m/z): [M+Na]+calcd. for C14H28O5Na 299.1829, found 299.1838; 1H NMR
(400 MHz, CD3OD): δ 4.64 (s, 1H), 3.74 (m, 5H), 3.51 (ddd, J = 11.4, 9.3, 4.5 Hz, 1H), 1.94
(dddd, J = 13.0, 4.4, 3.2, 1.0 Hz, 1H), 1.76 (ddd, J = 13.1, 11.3, 3.1 Hz, 1H), 1.44 (m, 8H), 1.21
(m, 3H), 1.14 (dd, J = 6.3, 1.9 Hz, 3H), 1.12 (d, J = 6.0 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ
96.1; 71.6; 70.0; 69.5; 68.34; 68.28; 39.5; 37.2; 35.4; 26.0; 25.9; 24.0; 19.2; 17.9.
Method B:
Representative procedure for hydrolysis with LiOH/MeOH - synthesis of asc-C10-OH:
To a suspension of 141.3 mg (0.2756 mmol) saturated alcohol 11 in 20 mL MeOH was
added 20 mL sat. 1M LiOH at once. The resulting solution was allowed to stir at 23 oC for 24 h.
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10 mL 20% iPrOH in CH2Cl2 was added to the reaction mixture, and the layers were separated.
The aqueous layer was extracted with an additional 5x 10 mL 20% iPrOH in CH2Cl2. Solid
NaCl was then added until saturation was obtained, and the aqueous layer was further extracted
with 3 x 10 mL 20% iPrOH in CH2Cl2. The combined organic layers were dried over Na2SO4
and filtered.

Evaporation of solvent afforded 117.2 mg of an oil.

Silica gel column

chromatography (46.72 g silica gel, gradient run from 5% iPrOH in CH2Cl2 to 20% iPrOH in
CH2Cl2) afforded 78.9 mg (94%) of a colorless oil. [α]D25 = -35.3, c 1.43 (CH3OH); HRMS
(m/z): [M+Na]+calcd. for C16H32O5Na 327.2142, found 327.2133; 1H NMR (400 MHz, CD3OD):
δ 4.64 (s, 1H), 3.69 (m, 4H), 3.52 (ddd, J = 11.3, 9.3, 4.6 Hz, 1H), 1.95 (dt, J = 13.1, 3.8 Hz,
1H), 1.76 (m, 1H), 1.44 (m, 12H), 1.21 (d, J = 6.2 Hz, 3H), 1.13 (dd, J = 9.9, 6.1 Hz, 6H); 13C
NMR (100 MHz, CD3OD): δ 97.7; 72.6; 71.3; 70.1; 68.7; 68.4; 40.3; 38.5; 36.1; 30.9; 30.8; 27.0;
26.9; 23.6; 19.5; 18.2.
Synthesis of asc-C9-OH:
Started with 344.5 mg (0.6909 mmol) alcohol 10 and 49.0 mL sat. 1 M LiOH in 49.0 mL
MeOH. Purified to obtain 178.5 mg (89%) of a colorless oil. [α]D25 = -49.1, c 2.53 (CH3OH);
HRMS (m/z): [M+Na]+calcd. for C15H30O5Na 313.1985, found 313.1979; 1H NMR (400 MHz,
CD3OD): δ 4.63 (s, 1H), 3.69 (m, 4H), 3.51 (ddd, J = 11.4, 9.4, 4.6 Hz, 1H), 1.94 (dt, J = 13.1,
3.9 Hz, 1H), 1.76 (ddd, J = 13.2, 11.3, 3.0 Hz, 1H), 1.42 (m, 10H), 1.21 (d, J = 6.1 Hz, 3H), 1.12
(dd, J = 10.3, 6.1 Hz, 6H);

13

C NMR (100 MHz, CD3OD): δ 97.7; 72.7; 71.3; 70.1; 68.7; 68.5;

40.3; 38.5; 36.1; 30.9; 27.03; 27.0; 23.6; 19.5; 18.3.
Synthesis of asc-C8-MK:
Started with 49.7 mg (0.103 mmol) ketone 12 and 7.1 mL sat. 1 M LiOH in 7.1 mL
MeOH. Purified to obtain 21.7 mg (77%) of a colorless oil. [α]D25 = -71.0, c 1.15 (CH3OH);
HRMS (m/z): [M+Na]+calcd. for C14H26O5Na 297.1672, found 297.1670; 1H NMR (400 MHz,
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CD3OD): δ 4.67 (s, 1H), 3.67 (m, 4H), 2.53 (t, J = 7.3 Hz, 2H), 2.16 (s, 3H), 1.98 (dddd, J =
13.0, 4.4, 3.2, 1.1 Hz, 1H), 1.79 (ddd, J = 13.0, 11.2, 3.1 Hz, 1H), 1.53 (m, 6H), 1.24 (d, J = 6.1
Hz, 3H), 1.15 (d, J = 6.0 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 209.8; 96.0; 71.1; 70.0; 69.4;
68.2; 43.8; 37.1; 35.4; 30.2; 25.4; 23.9; 19.1; 17.9.
Synthesis of asc-C9-MK:
Started with 234.1 mg (0.4714 mmol) ketone 13 and 33.3 mL sat. 1 M LiOH in 33.3 mL
MeOH. Purified to obtain 103.4 mg (76%) of a colorless oil. [α]D25 = -40.0, c 3.11 (CH3OH);
HRMS (m/z): [M+Na]+calcd. for C15H28O5Na 311.1829, found 311.1830; 1H NMR (250 MHz,
CD3OD): δ 4.63 (s, 1H), 3.62 (m, 4H), 2.48 (t, J = 7.3 Hz, 2H), 2.12 (s, 3H), 1.94 (dddd, J =
13.1, 4.4, 3.3, 1.0 Hz, 1H), 1.75 (ddd, J = 12.9, 11.1, 3.0 Hz, 1H), 1.44 (m, 8H), 1.20 (d, J = 6.0
Hz, 3H), 1.11 (d, J = 6.1 Hz, 3H); 13C NMR (100 MHz, CD3OD): δ 212.1; 97.5; 72.4; 71.2; 69.9;
68.3; 44.3; 38.2; 36.0; 30.2; 29.8; 26.7; 24.8; 19.3; 18.1.
Synthesis of asc-C10-MK:
Started with 36.9 mg (0.0723 mmol) ketone 14 and 5.3 mL sat. 1 M LiOH in 5.3 mL
MeOH. Purified to obtain 18.3 mg (84%) of a colorless oil. [α]D25 = -42, c 0.28 (CH3OH);
HRMS (m/z): [M+Na]+calcd. for C16H30O5Na 325.1985, found 325.1987; 1H NMR (250 MHz,
CD3OD): δ 4.63 (s, 1H), 3.62 (m, 4H), 2.47 (t, J = 7.3 Hz, 2H), 2.12 (s, 3H), 1.94 (dt, J = 13.1,
4.0 Hz, 1H), 1.75 (ddd, J = 13.0, 10.8, 2.9 Hz, 1H), 1.46 (m, 10H), 1.20 (d, J = 6.0 Hz, 3H), 1.11
(d, J = 6.1 Hz, 3H); 13C NMR (100 MHz, CD3OD): δ 212.2; 97.6; 72.5; 71.2; 70.0; 68.3; 44.3;
38.3; 36.0; 30.5; 30.2; 29.8; 26.7; 24.9; 19.3; 18.1.
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CHAPTER 2: SYNTHESIS AND BIOLOGICAL EVALUATION OF THE INFECTIVE
JUVENILE HORMONE OF HETERORHABDITIS BACTERIOPHORA
2.1

Introduction

2.1.1 Life Cycle
Heterorhabditis bacteriophora, an entomopathogenic nematode (roundworm insect
parasitoid), has a life cycle homologous to that of C. elegans (Figure 2.1).1 The parasite exists in
the soil as an infective juvenile (IJ), a dauer-like, nonfeeding and developmentally arrested stage
of the nematode. This infective juvenile seeks out an appropriate insect host and eventually
causes its death using its symbiotic relationship with Photorhabdus luminescens. This symbiotic
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Figure 2.1 Comparison of life cycles of C. elegans and H. bacteriophora
partner is a bacteria that resides in the gut of H. bacteriophora, and it allows the nematode to
develop, proliferate and kill its insect host, which acts as an essential source for nutrients.2 After
finding an insect host to inhabit, the IJ uses a relatively large buccal tooth to cut into the insect
cuticle and facilitate entry into the host’s gut.3 Approximately 30 minutes after the IJ selects and
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inhabits an insect hemocoel, the primary body cavity containing the circulatory fluid, it
regurgitates the symbiotic bacteria, which multiply and grow inside the gut of the insect, killing
it within 24 hours.4 In a study where P. luminescens bacteria were injected straight into the
instect’s homocoel, they exhibited a LC50 value of <10 cells.5
H. bacteriophora, after it regurgitates the P. luminescens bacteria, then recovers from the
IJ stage and enters the J4 stage, progressing towards adulthood.6 These adults then continue
through 1-2 generation cycles in the insect carcass, laying eggs that develop through J1-J4,
bypassing IJ formation. After these few cycles, when food availability from nutrients in the
insect host becomes low7 and population density is high, eggs begin to accumulate within the
nematode.8

The eggs then hatch while still inside the body cavity of H. bacteriophora,

producing pre-IJ’s which feed off of the tissues of its host mother, resulting in maternal death
and IJ production and release. This process is called endotokia matricida.
The study of the biological processes of H. bacteriophora is an important step in
biological pesticide research. H. bacteriophora or chemicals associated with its propagation and
parasitic properties could be used as a natural insecticide effective at eradicating a wide range of
insects without introducing other synthetic agents which could be harmful to the environment.
ARBICO Organics, a company focused on providing organic options for lawn and garden care,
is marketing the product NemaSeekTM. This product is simply H. bacteriophora nematodes
dispersed in a solution which is advertised as a pesticide for common garden pests that won’t
affect other animals. NemaSeekTM is mixed with water and sprayed over any infected area for
the control of unwanted insects.
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2.1.2 Symbiosis and Photorhabdus luminescens
H. bacteriophora has become of interest, in part, because of its interesting symbiotic
relationship with P. luminescens, a gram negative bacteria belonging to the family
Enterobacteriaceae.9 The bacterium is dependent upon the nematode for dispersal and food
supply (from the host insect). Naturally-occurring, free-living P. luminscens have not been
found in either water or soil samples, suggesting its dependence on a host.9 The nematode, in
turn, relies on P. luminescens for potential nutrients,9 protection from the insect host’s immune
system10 and deterrence of other microorganisms. H. bacteriophora reproduces more readily
when P. luminescens is prevalent, demonstrating that the bacterium may act as a source of
nutrients or partial food supply for the nematode.9 Once P. luminescens is regurgitated from H.
bacteriophora, it enters the stationary phase, secreting various lipases, phospholipases, proteases
and antibiotics into the insect host’s hemocoel. The antibiotics serve a two-part function:
protecting the developing nematode from the insect’s defense mechanisms and keeping the insect
cadaver from contamination by competing microorganisms.10
2.1.3 Regulation of Processes in H. bacteriophora Using Chemical Cues
As previously discussed, an array of small molecule chemical cues regulates various
processes in C. elegans such as dauer formation and recovery.

Like C. elegans, H.

bacteriophora use chemosensation to navigate the world around them. Several processes in the
nematode are regulated by small molecules. For example, H. bacteriophora find potential prey
through chemosensation of carbon dioxide, long-chain alcohols produced by insects11 and (E)beta-caryophyllene, a molecule secreted by plant roots after herbivore damage.12

This

chemosensation allows H. bacteriaphora to locate areas with high herbivore (potentially insect)
activity. Once H. bacteriophora has entered the insect host, regurgitation of the symbiont
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bacteria is induced by chemical cues in the insect’s hemolymph,4 and IJ recovery to L4 is
regulated by small molecules produced by the bacteria.13
The importance of chemosensation in regulating various aspects of H. bacteriophora’s
existence, as well as the similarity between the IJ stage of this nematode and the dauer phase of
C. elegans, has led Butcher and workers on a search for an IJ hormone, a small molecule that
would inhibit IJ recovery after endotokia matricida.1 Using bioassay-guided fractionation with
an IJ recovery assay, the IJ hormone was isolated (Figure 2.2). First, the infective juveniles were
cultivated in high densities by growing adults on a split Petri lipid-agar/saline plate. After
endotokia matricida, the infective juveniles would migrate from the lipid-agar side to the saline
section of the plate, where they were collected. The lipid-agar side of the plate was then
extracted with methanol.

Figure 2.2 Isolation of crude IJ hormones
This crude pheromone was then purified using C18 chromatography, and the fractions
were collected and analyzed for any biological activity. Fractions exhibiting activity towards
inhibiting IJ recovery to adulthood were further purified using reverse-phase HPLC. The active
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fractions from this round of purification contained a single compound, which was characterized
by NMR (1H,

13

C, dfq-COSY, HSQC, HMBC, and ROESY) and mass spectrometry. The

structure of ascaroside C11 ethanolamide (asc-C11EA 25) was then tentatively assigned (Figure
2.3).
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O
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asc-C11EA 25

Figure 2.3 Structure of asc-C11EA 25
2.2

Results and Discussion

2.2.1 Synthesis of Infective Juvenile Hormone
In order to verify the structure of the suggested hormone and to determine its exact
stereochemistry, the putative hormone 25 was to be synthesized first. After the compound was
created, its NMR spectra were then to be compared with the isolated hormone to confirm
structure and stereochemistry.

Initially, a synthetic scheme was envisioned where the

intermediate sugar 22, with a side chain containing 12 carbons and a terminal carboxylic acid,
would be functionalized with ethanolamine to give the desired amide 25. To accomplish this
synthesis, glycosylation of the previously synthesized (R)-(+)-11-dodecen-2-ol (15) with
dibenzoyl ascarylose 3 provided sugar 16 in 60% yield (Scheme 2.1). As with the glycosylations
-position was observed due to neighboring
group participation from the benzoate protecting group. These protecting groups block the
bottom face of the intermediate from attack by the alkenol 15. Oxidation of the terminal alkene
in compound 16 to the corresponding carboxylic acid was then attempted using KMnO4
oxidation.
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Scheme 2.1 Attempt at the synthesis of oxidized product 17
However, this method was unsuccessful. After oxidation, compound characterization (1H
NMR and

13

C NMR) indicated conversion to a carboxylic acid. But a closer look at the mass

spectrometry data illustrated that extensive loss of a side chain methylene group led to an
inseparable contaminant, illustrated by sugars 17 and 18 in Scheme 2.1. Another route towards
the synthesis of asc-C11EA 25 was then necessary (Scheme 2.2). In this synthetic outline, the
intermediate 12 carbon chain ester 22 would be made via cross metathesis of alkene 21 and
methyl acrylate.
The resulting ester, after hydrogenation of the alkene, could then undergo aminolysis to
give the desired putative IJ hormone, asc-C11EA 25. The first step in this new process was the
synthesis of starting alcohol 20 via an organocuprate addition to the less sterically hindered
carbon of (R)-(+)-propylene (Scheme 2.2). This was accomplished with the modest yield of
43%. Glycosylation of alcohol 20 with dibenzoyl ascarylose 3 gave the major β anomer 21 in
70% yield.
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Scheme 2.2 Synthesis of the saturated methyl ester 23
Alkene 21 underwent olefin cross metathesis with methyl acrylate, using Grubbs 2nd
generation ruthenium catalyst, to produce ascaroside 22 in an excellent yield of 91%. Unlike the
products of cross metathesis in Chapter 1 where a mixture of stereoisomers were produced, the
,-unsaturated methyl ester 22 was synthesized solely in the E configuration. This selectivity
is a result of the difference in stability between the cis and trans conformers. The cis isomer is
considerably less stable due to the strain between the carbonyl on the ester and the side chain
attached to the alkene. After purification of the , -unsaturated methyl ester, the double bond
was then hydrogenated using H2 and Pd/C at atmospheric pressure to afford the saturated ester
23 in 97% yield.
The last step in the synthesis of asc-C11EA 25 was the transformation of the terminal
ester to the ethanolamide moiety. In the first attempt, hydrolysis of the benzoate groups to give
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alcohols and the terminal methyl ester to the carboxylic acid was accomplished in 28% using
LiOH in MeOH (Scheme 2.3, Entry 1). Coupling of the carboxylic acid with ethanolamine using
HOBt and EDCI led to no desired product. No conversion of starting material was observed.
Several attempts at aminolysis of the ester 23 were then performed. Stirring of ester 23 in
ethanolamine at 80 C gave the desired product, asc-C11EA 25, in low yield (23%) (Scheme
2.3, Entry 2). Next, refluxing ethanolamine and the ester 23 in THF for two weeks only gave the
monodebenzoylated ethanolamide 26.
O

O

1)
BzO

O
OMe

5

O
LiOH

O
OBz

ethanolamine, HOBt

O

HO

MeOH

OH

5

EDCI, DMF

23

OH 24, 28%

O

O

O

2)
BzO

OMe

5

ethanolamine
80 deg. C

OH

25, 23%

O

O
3)
BzO

OBz

O
OMe

5

O
ethanolamine

O

O

BzO
THF, reflux

23

OH

26

O

O

LiOH
MeOH

HO

OH

O

HO

23

5

N
H

5

O

O
OBz

No reaction

5

N
H

OH

O
OH

25, 56% (over 2 steps)

Scheme 2.3 Attempts at aminolysis
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Hydrolysis with LiOH in MeOH was used to give the final product in 56% yield over 2
steps. Monodebenzoylation only occurred in the axial position possibly due to the gauche
interaction between the equatorial benzoate group and the methyl group on the ring, which
rendered it inaccessible to attack by ethanolamine.
Although 56% was a decent yield, the reaction was further optimized with the intention
of increasing reaction efficiency. Therefore, the solvent was changed from THF in favor of
pyridine (Scheme 2.4). Pyridine was seen as a more suitable solvent, because it would create a
polar environment and reflux at a higher temperature than THF, which would increase the
overall reactivity.

Aminolysis of 23 using ethanolamine in refluxing pyridine gave the

monodebenzoylated ethanolamide 26. This intermediate was then carried directly to the next
step. Hydrolysis of the remaining protecting benzoyl group gave desired product asc-C11EA 25
in 81% yield over 2 steps.
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Scheme 2.4 Successful synthesis of amide asc-C11EA 25
Although NMR spectra of both the isolated IJ hormone and asc-C11EA 25 were a match,
when the optical rotation of asc-C11EA 25 was compared to that of the naturally occurring
isolated IJ hormone, it was found that the two were not even close to one another. Therefore, the
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epimer 32 at the -1 center was synthesized via the same route as that of the synthesis of ascC11EA 25 (Scheme 2.5). The first step was the synthesis of (S)-(-)-11-dodecen-2-ol 28 from
(S)-(-)-propylene oxide 27. Once again, this synthesis was accomplished via an organocuprate
ring opening of the epoxide, providing compound 28 in 45% yield. Next in the synthesis was the
glycosylation of the alkenol 28 with dibenzoyl ascarylose 3 to give the sugar 29 in 51% yield.
This sugar then underwent cross metathesis with methyl acrylate, producing the ,-unsaturated
methyl ester 30 in the E configuration in 68%.

Hydrogenation of the alkene was then

successfully performed in an excellent yield of 97%. Aminolysis of 31 to form the epimer 32 at
the ω-1 center was straightforward in comparison to the synthesis of asc-C11EA 25. Reflux of
31 and ethanolamine in pyridine was sufficient in removing both benzoate groups and producing
epimer 32 in 72% yield. No hydrolysis was needed.
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Scheme 2.5 Synthesis of amide 32
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In comparison of the NMRs of the two synthesized epimers and that of the isolated
ascaroside hormone, it was clear that the ascaroside containing the R stereocenter (asc-C11EA)
was the correct structure for the naturally occurring IJ hormone of H. bacteriophora. It is likely
that the optical rotations of the synthetic asc-C11EA 25 and isolated hormones initially did not
match because of impurities present in the isolated hormone.
2.2.2 Biological Evaluation of IJ hormone and asc-C11
After synthesis of IJ hormone, biological evaluation was performed by the Butcher lab at
the University of Florida. This compound was submitted to an IJ recovery assay (Figure 2.4). In
this assay, the hormone was mixed with an agar medium containing a P. luminescens culture.
After incubation for 24 hours at 28C, eighty 7 or 8 day old infective juveniles were added to the
sample. This mixture was then allowed to incubate for an additional 18 hours at 28C, and all
resulting infective juveniles and recovered adult worms were counted.

Figure 2.4 IJ recovery assay
This compound exhibited an EC50 value of 25 nM in an IJ recovery assay, where an EC50
value is defined as the concentration at which the sample reached half of its maximal activity for
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inhibiting IJ recovery to adulthood. In order to confirm that this activity was mostly due to the
hormone and not to other molecules present in the crude pheromone, the IJ recovery activities of
both the hormone and the crude pheromone were compared. In an IJ recovery assay at a
concentration of 1M, the synthetic hormone asc-C11 EA and the crude pheromone exhibited
the comparable percent IJ formations of ~30% and ~40%. This indicates that the synthesized
asc-C11 EA is the active species of the crude pheromone.
In order to determine the ethanolamide moiety’s significance in IJ recovery inhibition,
asc-C11 24 was also synthesized (Scheme 2.6). Asc-C11 24 only differs structurally from the IJ
hormone by the absence of the ethanolamide moiety. Instead, it contains a terminal carboxylic
acid. Asc-C11 24 was synthesized via the hydrolysis of 23 with LiOH in tBuOH. tBuOH was a
better solvent than the previously utilized MeOH, due to better solvation of reagents. Asc-C11
24 has an EC50 value of 13 m in an IJ recovery assay, which is 500-fold less than that of the
ethanolamide-containing hormone. This decrease in potency demonstrates that the ethanolamide
moiety plays an integral role in IJ hormone receptor binding.
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Scheme 2.6 Synthesis of asc-C11 24
2.3

Conclusions
H. bacteriophora exists in the soil as an infective juvenile, which bears a remarkable

resemblance to the dauer stage in C. elegans. Like C. elegans, the IJ stage is characterized by its
non-aging nature and the cessation of feeding. This dauer-like stage of H. bacteriophora serves
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as an excellent model for studying parasitism and symbiosis. A compound was isolated by the
Butcher laboratory at the University of Florida which was determined to inhibit IJ recovery to
adulthood. Chapter 2 describes the synthesis and characterization of this naturally-occurring IJ
hormone asc-C11EA 25, its epimer at the -1 position 32, and asc-c11 24. The -1 (R) epimer
asc-C11EA 25 was originally thought to be the compound most likely to be the hormone due to
the structural similarity between this compound and ascarosides comprising the dauer
pheromone of C. elegans. At first, the synthesis of carboxylic acid 17 was attempted via KMnO4
oxidation of the alkene 16. However, this proved to be unsuccessful due to extensive loss of a
methylene group on the carbon side chain, which produced an inseparable mixture of desired
product and lower molecular weight impurity. As an alternate route towards the synthesis of
asc-C11EA 25, alkene 21 underwent cross metathesis with methyl acrylate to give ,unsaturated methyl ester 22, which was then hydrogenated to yield saturated ascaroside 23.
Aminolysis of compound 23 led to the desired product asc-C11EA 25. Optical rotation of the
synthesized asc-C11EA 25 did not match with that of the isolated hormone, so the -1 (S)
epimer 32 was synthesized. This synthesis was accomplished using the same route as ascC11EA 25 (glycosylation, cross metathesis, hydrogenation and aminolysis). After comparison
of the NMRs of the two epimers and the IJ hormone, it was determined that the correct structure
of the hormone was asc-C11EA 25. In an IJ recovery assay, the synthesized hormone was
shown to have an EC50 value of 25 mM. In order to determine the importance of the terminal
ethanolamide moiety on asc-C11EA 25, asc-C11 24 was synthesized via the hydrolysis of
methyl ester 23. The activity of this carboxylic acid was 500 times less than that of asc-C11EA
25, demonstrating that the ethanolamide moiety was crucial in inhibiting IJ recovery.
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2.4

Experimental

2.4.1 Procedures and Characterization
Representative procedure for epoxide opening – synthesis of 20:
To a suspension of 82.4 mg (3.39 mmol) of magnesium turnings in 0.44 mL dry THF was
added 0.52 mL (3.4 mmol) 7-bromo-1-heptene in 2.9 mL dry THF dropwise over the course of 4
minutes. The resulting suspension was brought to reflux and stirred for 12 h until all magnesium
had been consumed. The resulting cloudy, pale-yellow mixture was allowed to cool to 25°C. To
a separate flask was added 34.2 mg (0.238 mmol) CuBr in 5 mL dry THF. This suspension was
cooled to -78°C.

To this chilled suspension was added the previously synthesized 7-

heptenylmagnesium bromide dropwise over 3 minutes via syringe. This resulting suspension
was allowed to stir for 10 minutes, upon which it turned dark gray with black solids. To this
suspension was added 0.17 mL (2.4 mmol) (R)-(+)-propylene oxide at once, upon which it
turned from dark gray to black. The suspension was allowed to warm to 25°C and was stirred
for 3 h. To the black suspension was added 4 mL sat. NH4Cl at once. The aqueous layer was
separated from the organic layer and then extracted with 3 x 10 mL THF. The resulting organic
extracts were dried over MgSO4 and filtered to obtain 509.3 mg of dark yellow oil. Silica gel
column chromatography (54.9 g silica gel, 20% ethyl acetate in hexanes) afforded 225.2 mg
(43%) of a colorless oil. [α]D25 = -19.8, c 1.87 (CH2Cl2); IR (cm-1): 3334; 1H NMR (400 MHz,
CDCl3): δ 5.79 (ddt, 1H, J=17.1 Hz, J=10.2 Hz, J=6.7 Hz); 4.97 (d, 1H, J=17.2 Hz); 4.91 (d, 1H,
J=10.2 Hz); 3.76 (m, 1H); 2.02 (q, 2H, J=6.9 Hz); 1.36 (m, 10H); 1.16 (d, 3H, J=6.2 Hz);

13

C

NMR (100 MHz, CDCl3): δ 139.1; 114.2; 68.2; 39.3; 33.8; 29.5; 29.1; 28.8; 25.7; 23.5.
Representative procedure for glycosylation – synthesis of 21:
A suspension of 500.3 mg (1.404 mmol) dibenzoyl ascarylose 3, 350.4 mg (2.242 mmol)
alcohol 20 and 166.0 mg 4Å molecular sieves in 16 mL CH2Cl2 was cooled to 0oC. To this
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suspension was added 0.77 mL (6.1 mmol) BF3.OEt2 at once. The resulting suspension was
stirred at 0oC for 2.5 h. 20 mL saturated NaHCO3 solution was then added. Upon cessation of
effervescence, the aqueous layer was separated from the organic layer and then extracted with 3
x 10 mL 20% iPrOH in CH2Cl2. The resulting organic extracts were dried over MgSO4 and
filtered to obtain 847.3 mg of oil. Silica gel column chromatography (53 g silica gel, gradient
run from 50% hexanes in CH2Cl2 to 100% CH2Cl2) afforded 487.6 mg (70%) of a colorless
syrup. [α]D25 = -14.0, c 2.33 (CH2Cl2); IR (cm-1): 1722; HRMS (m/z): [M+Na]+ calcd. for
C30H38O6Na 517.2561, found 517.2564; 1H NMR (400 MHz, CDCl3): δ 8.12 (d, 2H, J=7.2 Hz);
8.05 (d, 2H, J=7.2 Hz); 7.58 (t, 2H, J=6.8 Hz); 7.46 (m, 4H); 5.82 (ddt, 1H, J=17.1, J=10.2 Hz,
J=6.7 Hz); 5.19 (td, 1H, J=10.5 Hz, J=4.1 Hz); 5.15 (m, 1H); 5.00 (d, 1H, J=17.2 Hz); 4.96 (s,
1H); 4.94 (d, 1H, J=11.1 Hz); 4.13 (dq, 1H, J=9.7 Hz, J=6.2 Hz); 3.85 (m, 1H); 2.42 (dt, 1H,
J=13.3 Hz, J=3.4 Hz); 2.22 (td, 1H, J=11.0 Hz, J=12.4 Hz, J=2.9 Hz); 2.07 (q, 2H, J=6.8 Hz);
1.65 (m, 1H); 1.45 (m, 9H); 1.29 (d, 3H, J=6.2 Hz), 1.19 (d, 3H, J=6.0 Hz); 13C NMR (100 MHz,
CDCl3): δ 165.8; 165.6; 139.1; 133.2; 133.1; 130.0; 129.8; 129.6; 128.4; 114.2; 93.8; 72.6; 71.2;
70.7; 66.9; 37.1; 33.8; 29.7; 29.4; 29.1; 28.9; 25.7; 19.2; 17.9.
Representative procedure for cross metathesis – synthesis of 22:
To a solution of 480.2 mg (0.9367 mmol) alkene 21 and 0.42 mL (4.7 mmol) methyl
acrylate in 29.8 mL CH2Cl2 at reflux was added 79.5 mg (0.0937 mmol) Grubbs 2nd generation
ruthenium catalyst at once. The resulting solution was allowed to stir at reflux for 6 h. The
reaction mixture was concentrated to 404.0 mg of brown oil. Silica gel column chromatography
(41 g silica gel, gradient run from 2% diethyl ether in hexanes to 10% diethyl ether in hexanes)
afforded 485.1 mg (91%) of a yellow oil. [α]D25 = -1.3, c 2.75 (CH2Cl2); IR (cm-1): 1721; HRMS
(m/z): [M+Na]+ calcd. for C32H40O8Na 575.2615, found 575.2606; 1H NMR (400 MHz, CDCl3):
δ 8.11 (d, 2H, J=7.1 Hz); 8.04 (d, 2H, J=7.2 Hz); 7.58 (t, 2H, J=7.2 Hz); 7.46 (m, 4H); 6.98 (dt,
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1H, J=15.6 Hz, J=6.9 Hz); 5.82 (d, 1H, J=15.6 Hz); 5.18 (td, 1H, J=10.5 Hz, J=4.0 Hz); 5.15 (m,
1H); 4.95 (s, 1H); 4.11 (dq, 1H, J=9.7 Hz, J=6.1 Hz); 3.84 (m, 1H); 3.70 (s, 3H); 2.42 (dt, 1H,
J=13.3 Hz, J=3.7 Hz); 2.22 (m, 3H); 1.67 (m, 1H); 1.43 (m, 9H); 1.28 (d, 3H, J=6.2 Hz); 1.19 (d,
3H, J=6.0 Hz); 13C NMR (100 MHz, CDCl3): δ 167.1; 165.7; 165.6; 149.6; 133.2; 133.1; 130.0;
129.8; 129.5; 128.4; 120.9; 93.8; 72.6; 71.2; 70.6; 66.9; 51.3; 37.0; 32.1; 29.7; 29.3; 29.1; 28.0;
25.6; 19.1; 17.8.
Representative procedure for hydrogenation – synthesis of 23:
A suspension of 422.8 mg (0.7650 mmol) unsaturated ester 22 and 50.4 mg 10 %
palladium on activated carbon in 46.0 mL EtOAc was vacuum purged and back filled with H2
from a balloon. The resulting suspension was allowed to stir at 23oC for 22 h. The reaction
mixture was filtered through Celite® and concentrated to obtain 411.5 mg (97%) of colorless oil
that required no further purification. [α]D25 = -2.1, c 4.04 (CH2Cl2); IR (cm-1): 1722; HRMS
(m/z): [M+Na]+ calcd. for C32H42O8Na 577.2772, found 577.2779; 1H NMR (400 MHz, CDCl3):
δ 8.11 (d, 2H, J=7.4 Hz); 8.04 (d, 2H, J=7.4 Hz); 7.57 (t, 2H, J=6.8 Hz); 7.45 (m, 4H); 5.18 (td,
1H, J=10.4 Hz, J=4.2 Hz); 5.15 (m, 1H); 4.95 (s, 1H); 4.12 (dq, 1H, J=9.7 Hz, J=6.1 Hz); 3.84
(m, 1H); 3.64 (s, 3H); 2.42 (dt, 1H, J=13.3 Hz, J=4.1 Hz); 2.29 (t, 2H, J=7.5 Hz); 2.21 (td, 1H,
J=12.4 Hz, J=2.8 Hz); 1.70 (m, 3H); 1.42 (m, 11H); 1.28 (d, 3H, J=6.2 Hz); 1.18 (d, 3H, J=6.0
Hz);
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C NMR (100 MHz, CDCl3): δ 174.1; 165.6; 165.5; 133.1; 133.0; 129.9; 129.7; 129.5;

128.3; 93.7; 72.5; 71.1; 70.6; 66.8; 51.3; 37.0; 33.9; 29.6; 29.4; 29.3; 29.1; 29.0; 25.6; 24.8; 19.1;
17.8.
Synthesis of asc C11 EA 25:
To a solution of 57.8 mg (0.104 mmol) saturated ester 23 in 4.3 mL pyridine at reflux
was added 0.1 mL (2 mmol) ethanolamine at once. The resulting solution was allowed to stir at
reflux for 48 h, in which time formation of the amide bond and monodebenzoylation occurred (as
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judged with 1H NMR) . The reaction mixture was concentrated to a yellow syrup. This syrup
was dissolved in 7.3 mL tBuOH. 7.3 mL 1M LiOH was then added at once. This solution was
allowed to stir for 24 h at 23oC. 1N HCl was then added dropwise until the reaction mixture
reached a pH=5. 5.0 mL 20% iPrOH in CH2Cl2 was then added to the acidified reaction mixture
and the layers were separated. The aqueous layer was extracted with an additional 6 x 5 mL 20%
iPrOH in CH2Cl2. The aqueous layer was then saturated with solid NaCl and further extracted
with 3 x 5 mL 20% iPrOH in CH2Cl2. The combined organic layers were dried over Na2SO4,
filtered and concentrated to a pale yellow oil. HPLC purification afforded 31.5 mg (81%, 2
steps) of a colorless oil. [α]D25 = -49.4, c 1.56 (CH3OH); IR (cm-1): 3314; 1651; HRMS (m/z):
[M+Na]+ calcd. for C19H37NO6Na 398.2513, found 398.2496; 1H NMR (700 MHz, CD3OD): δ
4.64 (s, 1H); 3.76 (m, 1H); 3.71 (m, 1H); 3.62 (dq, 1H, J=9.1 Hz, J=6.3 Hz); 3.58 (t, 2H, J=5.6
Hz); 3.51 (td, 1H, J=10.9 Hz, J=3.9 Hz); 3.28 (t, 2H, J=5.6 Hz); 2.20 (t, 2H, J=7.7 Hz); 1.95 (dt,
1H, J=13.0 Hz, J=3.3 Hz); 1.76 (td, 1H, J=12.3 Hz, J=2.8 Hz); 1.60 (m, 2H); 1.54 (m, 1H); 1.39
(m, 11H); 1.21 (d, 3H, J=6.3 Hz); 1.12 (d, 3H, J=5.6 Hz);
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C NMR (100 MHz, CD3OD): δ

176.8; 97.7; 72.6; 71.3; 70.1; 68.4; 61.8; 43.0; 38.5; 37.2; 36.1; 30.8; 30.7; 30.6; 30.4; 27.1; 27.0;
19.5; 18.3.
Synthesis of 28 (Same procedure as 20):
HRMS (m/z): [M+H]+ calcd. for C10H21O 157.1587, found 157.1591; 1H NMR (250
MHz, CDCl3): δ 5.81 (m, 1H); 4.95 (m, 2H); 3.78 (m, 1H); 2.05 (q, 2H, J=6.3 Hz); 1.40 (m,
11H); 1.19 (d, 3H, J=7.5 Hz).
Synthesis of 29 (Same procedure as 21):
HRMS (m/z): [M+Na]+ calcd. for C30H38O6Na 517.2561, found 517.2569; 1H NMR (400
MHz, CDCl3): δ 8.12 (m, 2H); 8.05 (m, 2H); 7.59 (m, 2H); 7.47 (m, 4H); 5.82 (m, 1H); 5.18 (m,
2H); 5.02 (dq, 1H, J=16.0Hz, J=4.0 Hz); 4.93 (m, 2H); 4.17 (m, 1H); 3.80 (sextet, 1H, J=8.0 Hz);
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2.41 (dt, 1H, J=16.0 Hz, J=3.6 Hz); 2.22 (m, 1H); 2.05 (m, 2H); 1.59 (m, 1H); 1.40 (m, 9H); 1.29
(d, 6H, J=6.0 Hz); 13C NMR (62.5 MHz, CDCl3): δ 165.74; 165.66; 139.2; 133.2; 133.1; 130.0;
129.8; 129.6; 128.4; 114.1; 96.1; 75.4; 71.0; 70.7; 66.8; 36.4; 33.8; 29.7; 29.5; 29.0; 28.9; 25.3;
21.3; 17.8.
Synthesis of 30 (Same procedure as 22):
HRMS (m/z): [M+Na]+ calcd. for C32H40O8Na 575.2615, found 575.2623; 1H NMR (400
MHz, CDCl3): δ 8.12 (m, 2H); 8.05 (m, 2H); 7.58 (m, 2H); 7.46 (m, 4H); 6.97 (dt, 1H, J=16.0
Hz, J=8.0 Hz); 5.82 (dt, 1H, J=15.6 Hz, J=2.0 Hz); 5.19 (m, 2H); 4.92 (s, 1H); 4.17 (m, 1H);
3.79 (m, 1H); 3.71 (s, 3H); 2.41 (dt, 1H, J=12.0 Hz, J=3.9 Hz); 2.20 (m, 3H); 1.59 (m, 1H); 1.39
(m, 9H); 1.28 (d, 6H, J=6.0 Hz).
Synthesis of 31 (Same procedure as 23):
HRMS (m/z): [M+Na]+ calcd. for C32H42O8Na 577.2772, found 577.2789; 1H NMR (400
MHz, CDCl3): δ 8.12 (d, 2H, J=8.0 Hz); 8.05 (d, 2H, J=8.0 Hz); 7.58 (m, 2H); 7.47 (m, 4H);
5.19 (m, 2H); 4.92 (s, 1H); 4.17 (m, 1H); 3.80 (m, 1H); 3.66 (s, 3H); 2.42 (dt, 1H, J=12.0 Hz,
J=4.0 Hz); 2.30 (t, 2H, J=7.8 Hz); 2.22 (m, 1H); 1.62 (m, 3H); 1.40 (m, 11H); 1.30 (d, 3H, J=6.5
Hz); 1.29 (d, 3H, J=6.2 Hz);

13

C NMR (100 MHz, CDCl3): δ 174.3; 165.8; 165.7; 133.21;

133.15; 130.1; 129.94; 129.87; 129.6; 128.4; 96.1; 75.5; 71.0; 70.8; 66.9; 51.4; 36.5; 34.1; 29.7;
29.6; 29.4; 29.2; 29.1; 25.3; 24.9; 21.3; 17.8.
Synthesis of 32:
HRMS (m/z): [M+Na]+ calcd. for C19H37NO6Na 398.2513, found 398.2522; 1H NMR
(400 MHz, CD3OD): δ 4.58 (s, 1H); 3.73-3.61 (m, 3H); 3.57 (t, 2H, J=5.8 Hz); 3.50 (m, 1H);
3.27 (t, 2H, J=5.8 Hz); 2.18 (t, 2H, J=7.7 Hz); 1.93 (dt, 1H, J=13.2 Hz, J=3.6 Hz); 1.76 (td, 1H,
J=11.4 Hz, J=3.0 Hz); 1.59 (m, 2H); 1.50 (m, 1H); 1.37 (m, 11H); 1.20 (d, 3H, J=6.2 Hz); 1.19
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(d, 3H, J=6.2 Hz);

13

C NMR (100 MHz, CD3OD): δ 176.7; 100.2; 75.6; 71.0; 69.7; 68.4; 61.7;

42.9; 37.5; 37.1; 35.9; 30.7; 30.5; 30.35; 30.26; 27.0; 26.4; 21.7; 18.0.
Synthesis of asc C11 (free acid) 24:
To a suspension of 55.8 mg (0.101 mmol) saturated ester 23 in 7.9 mL tBuOH was added
7.9 mL sat. 1M LiOH at once. The resulting solution was allowed to stir at 23oC for 19 h. 1N
HCl was then added dropwise until the reaction mixture reached a pH=3. 5.0 mL 20% iPrOH
in CH2Cl2 was added to the acidified reaction mixture, and the layers were separated. The
aqueous layer was extracted with an additional 8 x 5 mL 20% iPrOH in CH2Cl2. Solid NaCl was
then added until saturation was obtained, and the aqueous layer was further extracted with 3 x 5
mL 20% iPrOH in CH2Cl2. The combined organic layers were dried over Na2SO4 and filtered.
Evaporation of solvent afforded 128.3 mg of an oil. HPLC purification afforded 19.4 mg (58%)
of a colorless oil. [α]D25 = -54.5, c 0.99 (CH3OH); IR (cm-1): 3390; 1737; HRMS (m/z): [M+Na]+
calcd. for C17H32O6Na 355.2091, found 355.2074; 1H NMR (400 MHz, CD3OD): δ 4.68 (s, 1H);
3.77 (m, 2H); 3.68 (m, 1H); 3.58 (td, 1H, J=10.3 Hz, J=4.4 Hz); 2.29 (t, 2H, J=7.6 Hz); 2.06 (dt,
1H, J=13.0 Hz, J=3.8 Hz); 1.83 (td, 1H, J=12.3 Hz, J=2.9 Hz); 1.58 (m, 3H); 1.34 (m, 14H); 1.20
(d, 3H, J=6.1 Hz); 1.11 (d, 3H, J=6.1 Hz);

13

C NMR (400 MHz, CDCl3): δ 174.5; 96.0; 71.6;

69.8; 69.3; 68.1; 37.1; 35.1; 34.1; 29.4; 29.3; 29.1; 29.0; 25.6; 24.9; 18.9; 17.6.
2.5
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CHAPTER 3: DEVELOPMENT OF NOVEL VISIBLE LIGHT-PROMOTED METHOD
FOR SELENO-AND TELLUROFUNCTIONALIZATION AND SYNTHESIS OF γLYCORANE
3.1

Introduction
The first organoselenium compound, diethyl selenide, was synthesized in 1836.1 Since

then, organoselenium chemistry has become an integral part of organic synthesis. In the 1950’s,
the addition of PhSeY (formed from PhSeX (X=Cl or Br) and AgY (Y=OAc)) to alkenes was
introduced.2 Selenocyclizations using PhSeX were the logical next step.3 The mechanism for
these transformations is well known.4 Initially, a seleniranium ion intermediate is formed and
then attacked by a nucleophile, resulting in a stereospecific anti-addition (Scheme 3.1).

OH

PhSeX

O

PhSe

OH

SePh

Scheme 3.1 Mechanism for selenocyclization
Selenofunctionalization has played an integral role in the synthesis of many natural and
non-natural products.5 Organoselenides act as important intermediates which can be transformed
into the desired products via several methods.

One method for manipulation of the

selenofunctionalization product is C-Se bond homolysis.6 This reaction usually takes place as a
result of abstraction of the selenide by a tin or sulfur radical. As seen in Scheme 3.2, the
abstraction of selenide generates a carbon-centered radical, which can react further
intermolecularly or intramolecularly. For instance, this radical can cyclize onto an alkene.

PhSe

Bu3SnH, AIBN

Scheme 3.2 C-Se bond homolysis
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In addition to C-Se homolysis, a selenide intermediate can also undergo selenoxide
elimination to form an alkene.7

The first step in this elimination is the formation of the

selenoxide moiety via oxidation of the selenide (Scheme 3.3). Oxidation can be accomplished
using a variety of oxidations, the most common being hydrogen peroxide. Once the selenide is
oxidized, the intermediate then experiences an intermolecular syn elimination of the selenoxide
moiety to give the alkene.
O

O

O
SePh

SePh
O
H

O

Scheme 3.3 Selenoxide elimination
Another pathway for functionalizing a selenide intermediate is the Pummerer
rearrangement.8 In this step, a formed selenoxide interacts with an anhydride, usually acetic
anhydride, to yield an -acyloxy selenoester (Scheme 3.4). This product can then undergo
elimination, followed by the attack of an acetate anion to give the ester.9
O

O
OAc

O
SePh
R

O
H

O
OAc

O
SePh

SePh

R

R

AcO

SePh
R

Scheme 3.4 Pummerer rearrangement
Besides being important intermediates in organic synthesis, selenides have recently been
determined to have potent anti-cancer properties (Figure 3.1).10 The most studied and successful
anti-cancer agent is Ebselen®, selenide 33. It is currently in cancer clinical trials, and its possible
use as a therapeutic agent for stroke and bipolar disorder is also being investigated. The role that
selenium plays in this compound can be demonstrated by the complete inactivity of the sulfur
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analog. Compound 34 also displays high activity, with growth inhibition in the nanomolar
range, against several cancer cell lines including MCF-7, MCF-10A and HT-29.
O

Se
N

Se

O
S

N
S

O
33

34

Figure 3.1 Selenium-containing anti-cancer agents
The reagent for selenofunctionalization most often used is phenylselenyl bromide. It is
commercially available; however, due its short shelf life, water sensitivity and relatively high
price, it is generally synthesized via the reaction between diphenyl diselenide and molecular
bromine.11 Phenylselenyl bromide also has a high toxicity. In an attempt to replace this watersensitive, toxic, reactive species, Pandey and coworkers have developed a light-promoted
selenocyclization method using diphenyl diselenide and 1,2-dicyanonaphthalene (DCN).12
CN
CN

1,2-dicyanonaphthalene (DCN)
1

PhSeSePh

DCN* + PhSeSePh

OH

PhSe

+ DCN

PhSe

+ PhSe

O

PhSe

OH

SePh

Scheme 3.5 Pandey’s light-promoted selenocyclization
In this method, 1DCN*, promoted to its excited state by UV light, accepts an electron
from diphenyl diselenide (Scheme 3.5). The resulting diphenyl diselenide radical cation cleaves
to form phenyl selenide radical, which may combine with other radicals to reform Ph2Se2, and
phenyl selenide cation. This phenyl selenide cation is the species that reacts with the alkene to
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form the seleniranium ion, which then undergoes cyclization. The generated DCN radical anion
is oxidized by O2 to reform more catalyst. Although Pandey and coworkers were successful in
cyclizing a wide variety of substrates, their method suffered from several drawbacks. One was
that the use of UV light was essential to the transformation. UV light sources are expensive and
require complicated setups and cooling systems. Also, the yields obtained for the cyclized
products were mediocre, ranging from 40% to 74%.
3.2

Results and Discussion
Initially, this seleno- and tellurofunctionalization project began as an investigation of a

problem occurring in the α-selective glycosylation of alcohols with selenoglycosides, promoted
by visible light.13 After the successful glycosylation of various alcohols including cyclohexanol,
(-)-menthol and 1-octanol, the reaction was attempted using 4-penten-1-ol as the glucosyl
acceptor (Scheme 3.6).

The expected substitution of 4-penten-1-ol to the selenoglucoside

occurred only in low yields, mostly producing the cyclized ether. This phenomenon led to the
conclusion that there were possible competing reactions between the alkene, diphenyl diselenide
and tetrabromomethane which were interfering with the glycosylation process.

BnO
BnO
BnO

OBn
O
SePh

blue LEDs
Ph2Se2, CBr4

BnO
4-penten-1-ol, BnO
BnO
DTBMP, MeCN

OBn
O
O

O
+

SePh

Scheme 3.6 Attempted glycosylation using 4-peten-1-ol
In an effort to demonstrate that phenylselenyl bromide was the reactive species which
promoted the selenocyclizations, the blue LED irradiation of diphenyl diselenide and
tetrabromomethane in both dichloromethane and acetonitrile was monitored over time using 77Se
NMR. The resulting NMR spectra were compared to that of phenylselenyl bromide, which had
been obtained from the reaction of Br2 and diphenyl diselenide (Figure 3.2).11 After 1.5 h, only
52

diphenyl diselenide at δ 464 ppm and no phenylselenyl bromide was observed by

77

Se NMR.

After an additional 3 h, however, the phenylselenyl peak at δ 867 ppm was beginning to show.
Thus, phenylselenyl bromide was generated in situ in the course of the selenocyclization
reactions and was likely the reactive species.
Ph2Se2 + CBr4

blue LEDs

PhSeBr

CH2Cl2

1.5 h of irradiation

4.5 h of irradiation

Figure 3.2 77Se NMR Studies
To investigate any possible side reactions between the alkene moiety on 4-penten-1-ol
and the other reagents present in the reaction in Scheme 3.6, an NMR experiment was
performed.

In this experiment, an NMR tube was charged with diphenyl diselenide,

tetrabromomethane (or bromotrichloromethane) and 1-hexene (35) in either acetonitrile-D3 or
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chloroform-D and placed in a small beaker surrounded by blue LEDs (λmax = 455 nm). Over the
course of the reaction, the addition of PhSeBr across the alkene was observed (Scheme 3.7). The
relatively clean conversion of 1-hexene to the phenyl selenide/bromide adduct 36 was confirmed
by 1H NMR and 2D NMR. Purification of the reaction mixture by column chromatography
using silica gel, however, proved to be unproductive. Multiple attempts at purification were
performed. Upon reflection on this issue, it was determined that the phenyl selenide/ bromide
adduct was being hydrolyzed on the column to produce the phenyl selenide/ hydroxylated
compound 37.14 To remedy this situation, silica gel was dried and dry solvents were used to
elute the compound. After this was determined to be ineffective, dry neutral alumina was used
as the solid phase media, without success.

Even after taking these measures, the phenyl

selenide/bromine adduct was still hydrolyzed to the alcohol.
PhSeSePh, CBr4 or CBrCl3

Br

CDCl3 or CD3CN, blue LEDs

OH
purification

PhSe

PhSe

36

35

37

Scheme 3.7 Attempted addition of PhSeBr across an alkene
Since the bromide 36 appeared to be susceptible to nucleophilic attack, an intramolecular
selenocyclization was then attempted using 5-hexen-1-ol (38).

Initial experiments using 1

equivalent each of diphenyl diselenide and tetrabromomethane with a concentration of 5-hexen1-ol of 200 mM in various solvents resulted in low and variable yields of the cyclized product 39
as well as relatively long reaction times, often over 24 h. After observing that the diphenyl
diselenide was precipitating during the course of the reaction, a higher dilution of 50 mM was
attempted with exciting results. The yields at this dilution were a great improvement over those
at the higher concentration, and the reaction times were much shorter. At this time, it was also
observed that the reaction proceeded efficiently under air, with no effect on yield or reaction
54

time. In an effort to optimize the conditions for this selenocyclization reaction, a battery of
experiments using various solvents was performed (Table 3.1).
The use of tetrahydrofuran and diethyl ether (Entries 1 and 2) as solvent gave the
cyclized ether product 39 in 70% and 84% yield, respectively, in 24.5 h. Although the yields
were high, the reaction time was relatively long. The irradiation time and yield improved when
dichloromethane was used as solvent, with complete conversion in 11 h with a yield of 93%
(Entry 3).
Table 3.1 Solvent screen for selenocyclization of 5-penten-1-ol
blue LEDs (455 nm)

HO
38

CBr4 (1 equiv)
PhSeSePh (1 equiv)
solvent

O

SePh
39

Irradiation
Yield
Time (h)
(%)
1
THF
24.5
70
2
Et2O
24.5
84
3
CH2Cl2
11
93
4
CH3CN
6
91
5
iPrOH
3.5
85
6
EtOH
5.5
90
7
MeOH
4
98
8*
MeOH
7
82
‡
9
CH2Cl2
120
0
10†
CH2Cl2
120
0
a
All reactions were performed on a 0.6 mmol scale at a concentration of 50 mM. *Used CBrCl3
instead of CBr4. ‡Performed in the absence of light. †Performed in the absence of CBr4.
Entry

Solvent

The use of acetonitrile as solvent decreased the reaction time even further to 6 h, with a
similar yield of 91% (Entry 4). Isopropanol and ethanol as solvent produced reaction times of
just 3.5 h and 5.5 h, respectively, with yields reaching 85% and 90% (Entries 5 and 6). The best
combination of reaction time and yield was the result of using methanol as solvent. With
methanol as solvent, the irradiation time needed to completely consume the starting material was
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shortened to 4 h, and the yield was increased to 98% (Entry 7). Interestingly, no formation of the
alkoxyselenation product resulting from the attack of solvent molecules on the seleniranium
intermediate was observed. To determine the importance of the tetrabromomethane in the course
of the reaction, the less expensive bromotrichloromethane was used (Entry 8). Although the
reaction succeeded in generating the cyclization product, the yield was significantly lower (82%)
and the reaction time was almost doubled (7 h). Next, various controls were run. When the
reaction was run under the favored conditions without irradiation for 5 days, no product was
observed. This result demonstrates that the selenocyclization is promoted by light. For the next
control, tetrabromomethane was eliminated as a reagent, and starting material was not converted.
As such, tetrabromomethane plays an integral role in the reaction.
In order to expand our substrate scope, varying nucleophiles, chain lengths,
stereochemistries and complexities were chosen to demonstrate the utility of the developed
method (Table 3.2). To experiment with chain length, 4-penten-1-ol was irradiated with blue
LEDs using the optimized conditions of 1 equivalent each of diphenyl diselenide and
tetrabromomethane at a concentration of 50 mM. The resulting cyclized product was formed in
94% yield in 3.5 h (Entry 1). In order to demonstrate that the developed selenofunctionalization
method was successful for a range of nucleophiles, unprotected pentenamine was submitted to
the reaction conditions. Unfortunately, no cyclized product was formed. However, the reaction
was successful when the amine was protected to form either the Boc-protect amine or the methyl
carbamate. The Boc-protected amine was cyclized first under the standard conditions with
methanol as solvent. No pyrrolidine product was observed. After changing the solvent to
dichloromethane, the reaction proceeded as expected, and the Boc-protected amine was
converted to the desired product in a modest yield of 62% over the course of 3.5 h (Entry 2).
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The decrease in yield could have been due to the degradation of the Boc group of both
the starting material and product by in situ-generated HBr. Using the methyl carbamate as the
starting material instead of the Boc-protected analog as a way to circumvent degradation by HBr
successfully increased the yield to 78% (Entry 3) with a longer irradiation time of 7 h. The last
nucleophile that was explored was a carboxylic acid. When 4-pentenoic acid was irradiated with
diphenyl

diselenide

and

tetrabromomethane

in

methanol,

substantial

quantities

of

methoxyselenation products were observed. To avoid this issue, dichloromethane was used as
the solvent and gave the desired product in 95% yield over 4 h (Entry 4). All of the substrates in
this study thus far had involved the intramolecular attack of a pendant nucleophile.

To

demonstrate that the developed method was applicable to intermolecular systems, experiments
were envisioned where the starting alkene would be converted to the methoxyselenation product.
Cyclohexene was, therefore, reacted under the optimized conditions to give the expected
methoxyselenation product in 97% yield after 17 h of irradiation (Entry 5). The methoxy group
and phenyl selenide were on opposite faces due to the anti addition of methanol to the
seleniranium ion. The Ritter reaction of cyclohexene was then attempted to demonstrate the
intermolecular addition of acetonitrile and the following formation of the amide. Unfortunately,
the desired product was formed in only a low yield of 43% over a long irradiation time of 12
days (Entry 6).

The irradiation of 1-hexene under standard conditions also yielded the

methoxyselenation products (Entry 7). The product consisted of a 3.3:1 ratio of regioisomers
53a and 53b, favoring the Markovnikov addition product with a combined yield of 97% over 7 h.
Lastly, a secondary alcohol as nucleophile was utilized to give the product as a 1:1 mixture of
diastereomers in 99% yield in the relatively short reaction time of 4 h (Entry 8). It should be
noted that the purification via column chromatography of all selenocyclization products was
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facile, due to the clean conversion of the starting material and the polarity difference between the
product and the impurities (e.g. diphenyl diselenide).
Table 3.2 Substrate scope for selenofunctionalization
Entry

Substrate

1
2b

3

Yield
(%)

Product

40

, 41

42

, 43

MeO2CHN

94

62

78

44

, 45

4b

, 47

46
5

95

97
, 49

48
6c

43
, 51

50
OMe

SePh

7

53a
+

52

SePh
OMe
53b

97

(3.3:1)

8

99
, 55

54
(1:1)
a

All reactions were performed on a 0.6 mmol scale at a concentration of 50 mM. bReaction
performed in CH2Cl2 cReaction performed in CH3CN/H2O
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In order to demonstrate that the developed method was applicable to more complex
structures, the total synthesis of (±)-γ-lycorane, an Amaryllidaceae alkaloid, was undertaken.
This natural product contains an interesting pentacyclic ring system (Figure 3.3). Although (±)γ-lycorane itself does not exhibit any biological properties, it is often synthesized as a route to
more active lycorine alkaloids.15
H

H

H

O
N

O

TMS
(+/-)--lycorane

Figure 3.3 (±)-γ-lycorane
The first step in the synthesis involves the reduction of the known nitrile 56 to amine
57.20 The amine 57 was then coupled with commercially available piperonyl chloride 58 using
triethylamine in dichloromethane to form amide 59 in 63% yield over 2 steps. The standard
conditions for the developed visible light-promoted selenocyclization method were then applied
to amide 59. The solvent that gave the best yield for this reaction was determined to be
dichloromethane, which produced the desired perhydroindole 60 in 71% yield.

The

stereochemistry for this cyclized product was confirmed by 2D NMR (COSY and ROESY). The
COSY NMR experiment did not show any correlation between the two bridging hydrogen atoms,
while the ROESY NMR illustrated a strong correlation between the previously mentioned
hydrogen atoms. Both of these results confirm the anti addition of the amide onto the formed
seleniranium intermediate to give the cis-fused ring system 60 illustrated in Scheme 3.8. In the
next step in the synthesis of (±)-γ-lycorane, tributyltin hydride and AIBN were reacted with
phenyl selenide to produce the carbon-centered radical intermediate which would cyclize onto
the aromatic ring.

Unfortunately, the amide 63, a result of the carbon-centered radical
59

abstracting a hydrogen from tribuyltin hydride, formed in 31% yield. Also, the cyclization of the
radical intermediate onto the aromatic ring was not site-selective, giving the two regioisomers 61
and 62 as an inseparable 1:1 mixture with a combined yield of 37%.
O
Cl

O
58

LiAlH4

Et3N, CH2Cl2
(63%, 2 steps)

H2N
N

O

O

56

H
N

O
O

57

blue LEDs

59

PhSe
H

O

Ph2Se2 (1 equiv)
CBr4 (1 equiv)
CH2Cl2
(71%)

R3

N

O

Bu3SnH, AIBN (stoich.)
toluene, reflux

O
60
R1

R2

H

H

H

H

H

H

O
N

O

O
61 (R1 = H, R2, R3 = -OCH2O-)
62 (R1, R2 = -OCH2O-, R3 = H)
(37%, ~1:1)

N
O
63 (31 %)

Scheme 3.8 First attempt at the synthesis of (±)-γ-lycorane
To remedy this selectivity issue, a TMS protecting group was added to the aromatic ring
to form the blocked substrate 64 (Scheme 3.9). This protection was achieved via a directed ortho
metalation.16 The TMS-protected carboxylic acid 64 was coupled with amine 57 using HOBt,
TBTU and DIPEA in dichloromethane to form the TMS-protected amide 65 in 54% yield. When
attempts were made to cyclize the amine onto the cyclohexene ring using the developed
selenocyclization method in dichloromethane, the desired phenyl selenide 66 was not produced.
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Although cyclization was observed, it was determined that the HBr generated in situ was leading
to the protiodesilylation and removal of the TMS-protecting group.
To neutralize any acid formed during the course of the reaction, 1.2 equivalents of 2,6-ditert-butyl-4-methylpyridine (DTBMP) was added. After addition of base, the reaction proceeded
smoothly to give the cyclized product 66 in 85% yield. The tin-promoted cyclization of 66
mainly produced small amounts of cyclized product 68 (Scheme 3.10), but mainly forming the
hydrogen abstraction product 67 in yields ranging from 73% to 77%, depending upon the solvent
used. Various changes were made to the reaction conditions to increase the yield of the cyclized
product and decrease the amount of hydrogen abstraction. For example, both benzene and
cyclohexane were utilized as solvents, but both led to the major hydrogen abstraction product.
Slow addition of AIBN via syringe pump and varying the concentration of the phenyl selenide
66 were also attempted, with no increase in desired cyclized product 68.

O
OH

O

TMS O H2N
64

blue LEDs

O

Ph2Se2 (1 equiv)
CBr4 (1 equiv)
DTBMP (1.2 equiv)
CH2Cl2
(85%)

HOBt, TBTU

O

DIPEA, DMF
(54%)

O
TMS O

57
PhSe
H
N

O

H
N

H

TMS O
66

Bu3SnH, AIBN

O

benzene or
cyclohexane
(73-77%)

O

65

H
N

H

TMS O
67

Scheme 3.9 Addition of TMS-protecting group
The undesired amide 67 was assumed to be the product of the abstraction of hydrogen
from tributyltin hydride by the carbon-centered radical intermediate. Surmising that tributyltin
hydride was too reactive as a hydrogen donor, TTMSS, a much less reactive species, was used as
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an alternative.17 When this reagent was used in combination with AIBN, a separable mixture of
the desired cyclized product (44%) and the hydrogen abstraction product (41%) was formed. To
improve the yield of the cyclized product 68, several solvent systems were pursued. The
solvents chosen for the screen were toluene, cyclohexane and benzene which gave the
corresponding yields of 15%, 22% and 44% of the cyclized product 68. Once again, slow
addition of the AIBN via syringe pump and varying the concentration were also attempted to
decrease the amount of hydrogen abstraction product formed. Neither of these methods was
successful in increasing the yield of cyclization. In the final two steps in the synthesis of (±)-γlycorane, the amide was transformed into the amine via the reduction of the ketone by lithium
aluminum hydride and then submitted to acidic conditions (TFA) to remove the TMS group to
produce (±)-γ-lycorane in 68% yield. Overall, the Amaryllidaceae alkaloid was synthesized in
3.4% yield over 7 steps.

O

PhSe
H

H
N

O

H

TTMSS, AIBN

O

benzene, reflux

O

TMS O
66

H

H
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Scheme 3.10 TTMSS as radical initiator
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After the synthesis of (±)-γ-lycorane, the developed visible light-promoted
selenofunctionalization method was applied towards other systems. Tellurocyclizations were
attempted via the irradiation of alkenols with diphenyl ditelluride and tetrabromomethane. At
first, methanol was used as solvent for both the cyclization of 4-penten-1-ol and 5-penten-1-ol, as
it was the solvent of choice for selenofunctionalizations. However, this gave no desired cyclic
ether product. Dichloromethane was then used as an alternative solvent with success. Although
the yields were decreased and the reaction times were increased from those of
selenofunctionalization, tellurocyclization products were formed. With 4-penten-1-ol as the
substrate, the desired product was formed in 75% yield over 47 h (Entry 1). The structure of
compound 69 was confirmed by X-ray crystallography to be the dibromotelluride. When 5hexen-1-ol was submitted to the same conditions with dichloromethane as solvent, the cyclic
ether was again formed in 53% yield over the course of 44 h of irradiation (Entry 2). The
dibromotelluride 69 was reduced to the telluride with sodium borohydride in ethanol to give the
desired product in 99% yield.
Table 3.3 Visible light-promoted tellurofunctionalization
substrates
38, 40, 46

Entry

Substrate

blue LEDs (455 nm)
CBr4 (1 equiv)
PhTeTePh (1 equiv)
CH2Cl2

Reaction
Time (h)

products
69-71

Product

Yield
(%)

HO

1

2

a

40

38

47

75
69

44

53
70

Reactions were performed on a 0.6 mmol scale at a concentration of 50 mM.
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As demonstrated by
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Se NMR, phenylselenyl bromide is generated in situ during the

course of the selenocyclization reactions. We proposed that the formation of this reactive
species was due to the visible light-promoted homolysis of the Se-Se bond to generate two
phenyl selenide radicals. These phenyl selenide radicals then would abstract a bromine atom
from tetrabromomethane to form phenylselenyl bromide. In order to determine the mechanism
by which phenylselenyl bromide was generated, Gaussian 2009 calculations were performed by
Ranelka Fernando (Stanley group, LSU Department of Chemistry) who demonstrated that the
phenyl selenide radical abstraction of bromine from tetrabromomethane was favorable by -9.3
kcal/mol (Scheme 3.11). The fate of the by-product tribromomethyl radical was studied as well.
Some research suggests that the tribromomethyl radical can react to form tetrabromoethylene. In
order to test this theory within the realms of our reaction conditions, diphenyl diselenide was
irradiated with tetrabromomethane in both methanol and dichloromethane. GC-MS analysis of
the resulting reaction mixture did not show any evidence of tetrabromoethylene in solution. The
fate of the putative tribromomethyl radical is unknown.
Mechanism 1: Homolysis
h (455 nm)
PhX-XPh

CBr4

2 PhX

PhXBr + unidentified by-products

(X = Se, Te)

6-311G** calculations:
PhSe

PhSeBr

CBr4

CBr3

G = -9.3 kcal/mole

Mechanism 2: Photoinitiated Electron Transfer
PhX-XPh

h (455 nm)

PhX-XPh*

CBr4

PhX-XPh

PhXBr + unidentified by-products

Scheme 3.11 Mechanistic considerations
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Br

CBr3

A year after this work on seleno- and tellurofunctionalization was published, Xu and
coworkers demonstrated a potential mechanistic pathway resulting from the visible light
irradiation of diselenides.18 In this study, it was concluded that scrambling occurred when a
diaryl diselenide and dialkyl diselenide were irradiated, providing evidence towards the visible
light-promoted Se-Se bond homolysis theory.
3.3

Conclusions
In this project, a method was developed for the visible light-promoted seleno- and

tellurofunctionalization of alkenes. The method utilized mild, stable reagents with inexpensive
experimental setups. Optimization of the developed method was accomplished by screening
solvents, bromine sources, concentrations and light sources using 4-penten-1-ol as the starting
material. The best reaction conditions were the irradiation of the starting material with diphenyl
diselenide and tetrabromomethane as bromine source in methanol at a concentration of 50 mM.
The reaction proceeds under aerobic conditions, without any negative effects on yield. To prove
that selenofunctionalization was possible with a wide variety of substrates, starting materials
with different nucleophiles and chain lengths were irradiated under the optimized conditions to
give the desired functionalized products in good to excellent yields ranging from 43% to 99%.
The developed method was then applied to the total synthesis of Amaryllidaceae alkaloid, (±)-γlycorane, which was made in 3.4% yield in 7 steps from the commercially available starting
material. The key visible light-promoted selenocyclization reaction proceeded in excellent yield
(85%), and the stereochemistry was confirmed using 2D NMR (ROESY and COSY). Next,
tellurocyclization was explored. Using 4-penten-1-ol and 6-hexen-1-ol as substrates, the desired
cyclized products 40 and 38 were isolated in mediocre yields. Attempts at generating the
carbon-centered radical via C-Te bond cleavage were unsuccessful.
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The reactive species present in the selenofunctionalization reactions was PhSeBr. In
order to determine the mechanism by which PhSeBr was generated, computational studies were
performed. Computational data using Gaussian 2009 calculations demonstrated that the Se-Se
bond homolysis followed by selenide radical abstraction of bromine was favorable by -9.3
kcal/mole.

Xu and coworkers demonstrated the feasibility of diselenide radicals through

homolysis.
3.4

Experimental

3.4.1 General Methods
Flash column chromatography was performed using BDH 60Å silica gel. 1H NMR and
13

C NMR spectroscopy were performed on a Bruker AV-400, DPX 400 or DPX 250

spectrometer. Mass spectra were obtained using an Agilent 6210 electrospray time-of-flight
mass spectrometer. Unless otherwise noted, all materials were obtained from commercial
suppliers and used without further purification. Analytical TLC was conducted on aluminumbacked sheets (Merck, silica gel 60, F254). Compounds were visualized by UV absorption (254
nm) and staining with anisaldehyde or KMnO4.

Deuterated solvents were obtained from

Cambridge Isotope Labs. All solvents except MeOH, iPrOH and EtOH were purified according
to the method of Grubbs.19 MeOH, iPrOH and EtOH were obtained from Sigma-Aldrich®.
Diffraction data were obtained on a Bruker Kappa Apex-II DUO diffractometer using a graphite
monochromated Mo Kα radiation.
3.4.2 Experimental Setup
The

experimental

setup

and

reaction

conditions

for

the

seleno-

and

tellurofunctionalization transformations were simple. Blue LEDs were purchased from Creative
Lighting Solutions at a low cost and wrapped around the exterior of an evaporating dish. The
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reaction flasks were placed directly up against the light and stirred vigorously. Since air did not
have any effect on yield, a septum was placed on the reaction vial under air just to eliminate the
possibility of stray particles from falling into the reaction. The solution temperature stayed
within the range 25-29 °C, demonstrating that adventitious heating by the LEDs was not
responsible for any reactivity of the reaction.

There was no workup for the seleno- and

tellurofunctionalizations. Once the reaction was complete by TLC, the solvent was removed in
vacuo.

Figure 3.4: Experimental setup
3.4.3 Procedures and Characterization
Representative procedure for selenocyclization – synthesis of 39:
To a round bottom flask containing 199.0 mg (0.6000 mmol) of tetrabromomethane and
187.3 mg (0.6000 mmol) diphenyl diselenide in 12.0 mL CH3OH was added 72 µL (0.60 mmol)
38 at once. The reaction was placed approximately 5 mm from the irradiation source (blue LEDs
– see Figure 3.4) and allowed to stir under irradiation for 4 h when complete conversion of
starting alcohol was observed by TLC. The crude reaction mixture was then concentrated in
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vacuo. Silica gel chromatography (silica gel, gradient run from 100% hexanes to 10% ethyl
acetate in hexanes) afforded 149.5 mg (98%) of a pale yellow oil. 1H NMR (400 MHz, CDCl3):
δ 7.50 (m, 2H), 7.22 (m, 3H), 4.00 (m, 1H), 3.44 (m, 2H), 3.06 (dd, J = 12.2, 6.9 Hz, 1H), 2.92
(dd, J = 12.1, 5.6 Hz, 1H), 1.78 (m, 2H), 1.51 (m, 3H), 1.31 (m, 1H);

13

C NMR (100 MHz,

CDCl3): δ 132.5, 130.9, 129.1, 126.8, 77.2, 68.8, 33.8, 31.9, 25.9, 23.5; HRMS m/z calcd for
C12H17OSe (M+H)+ 257.0433, found 257.0445.
Synthesis of 41:
Started with 199.0 mg (0.6000 mmol) tetrabromomethane, 187.3 mg (0.6000 mmol)
diphenyl diselenide and 62 µL (0.60 mmol) 40 in 12.0 mL CH3OH. Irradiated for 3.5 h. Solvent
was then removed in vacuo. Silica gel chromatography (silica gel, gradient run from 100%
hexanes to 10% ethyl acetate in hexanes) afforded 135.7 mg (94%) of a colorless oil. 1H NMR
(400 MHz, CDCl3): δ 7.52 (m, 2H), 7.24 (m, 3H), 4.09 (quintet, J = 6.7 Hz, 1H), 3.91 (m, 1H),
3.76 (m, 1H), 3.12 (dd, J = 12.1, 5.8 Hz, 1H), 2.99 (dd, J = 12.2, 6.8 Hz, 1H), 2.06 (m, 1H), 1.91
(m, 2H), 1.62 (m, 1H);

13

C NMR (100 MHz, CDCl3): δ 132.5, 130.3, 129.0, 126.8, 78.3, 68.3,

33.0, 31.5, 25.9; HRMS m/z calcd for C11H15OSe (M+H)+ 243.0276, found 243.0283.
Synthesis of 43:
Started with 199.0 mg (0.6000 mmol) tetrabromomethane, 187.3 mg (0.6000 mmol)
diphenyl diselenide and 111.0 mg (0.6000 mmol) 42 in 12.0 mL CH2Cl2. Irradiated for 3.5 h.
Solvent was then removed in vacuo. Silica gel chromatography (silica gel, gradient run from
100% hexanes to 10% ethyl acetate in hexanes) afforded 127.2 mg (62%) of a colorless oil. 1H
NMR (400 MHz, CD3CN, 343K): δ 7.59 (m, 2H), 7.30 (m, 3H), 4.01 (m, 1H), 3.36 (m, 3H), 2.98
(dd, J = 12.0, 9.4 Hz, 1H), 2.07 (m, 1H), 1.91 (m, 2H), 1.79 (m, 1H), 1.43 (s, 9H);
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13

C NMR

(125 MHz, (CD3)2SO): δ 153.2, 131.4, 129.7, 128.8, 126.3, 78.3, 56.5, 46.3, 30.9, 30.0, 27.9,
22.4; HRMS m/z calcd for C16H24NO2Se (M+H)+ 342.0967, found 342.0985.
Synthesis of 45:
Started with 199.0 mg (0.6000 mmol) tetrabromomethane, 187.3 mg (0.6000 mmol)
diphenyl diselenide and 85.9 mg (0.600 mmol) 44 in 12.0 mL CH2Cl2. Irradiated for 7 h.
Solvent was then removed in vacuo. Silica gel chromatography (silica gel, gradient run from
100% hexanes to 30% ethyl acetate in hexanes) afforded 138.7 mg (78%) of a colorless oil. 1H
NMR (400 MHz, CDCl3, 329K): δ 7.56 (m, 2H), 7.25 (m, 3H), 4.08 (m, 1H), 3.66 (s, 3H), 3.42
(m, 3H), 2.90 (m, 1H), 2.03 (m, 1H), 1.91 (m, 2H), 1.80 (m, 1H);

13

C NMR (100 MHz, CDCl3,

329K): δ 155.6, 132.4, 130.5, 129.2, 126.9, 57.9, 52.30, 52.26, 47.2, 30.9, 23.6; HRMS m/z
calcd for C13H18NO2Se (M+H)+ 300.0498, found 300.0497.
Synthesis of 47:
Started with 199.0 mg (0.6000 mmol) tetrabromomethane, 187.0 mg (0.6000 mmol)
diphenyl diselenide and 61 µL (0.60 mmol) 46 in 12.0 mL CH2Cl2. Irradiated for 4 h. Solvent
was then removed in vacuo. Silica gel chromatography (silica gel, gradient run from 100%
hexanes to 50% ethyl acetate in hexanes) afforded 146.5 mg (95%) of a colorless oil. 1H NMR
(400 MHz, CDCl3): δ 7.54 (m, 2H), 7.28 (m, 3H), 4.65 (m, 1H), 3.28 (dd, J = 12.8, 4.8 Hz, 1H),
3.01 (dd, J = 12.8, 7.9 Hz, 1H), 2.49 (m, 3H), 1.95 (m, 1H);

13

C NMR (100 MHz, CDCl3): δ

176.7, 133.4, 129.5, 129.0, 127.8, 79.5, 32.0, 28.9, 27.8; HRMS m/z calcd for C11H13O2Se
(M+H)+ 257.0075, found 257.0071.
Synthesis of 49:
Started with 199.0 mg (0.6000 mmol) tetrabromomethane, 187.3 mg (0.6000 mmol)
diphenyl diselenide and 61 µL (0.60 mmol) 48 in 12.0 mL CH3OH. Irradiated for 17 h. Solvent
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was then removed in vacuo. Silica gel chromatography (silica gel, gradient run from 100%
hexanes to 10% ethyl acetate in hexanes) afforded 157.3 mg (97%) of a colorless oil. 1H NMR
(400 MHz, CDCl3): δ 7.58 (m, 2H), 7.24 (m, 3H), 3.36 (s, 3H), 3.26 (m, 1H), 3.16 (m, 1H), 2.13
(m, 1H), 1.99 (m, 1H), 1.71 (m, 1H), 1.58 (m, 1H), 1.49 (m, 1H), 1.27 (m, 3H);

13

C NMR (100

MHz, CDCl3): δ 135.3, 129.0, 128.8, 127.4, 82.2, 26.4, 47.4, 32.1, 30.3, 25.8, 23.5; HRMS m/z
calcd for C12H15Se (M - OMe)+ 239.0333, found 239.0338.
Synthesis of 51:
Started with 199.0 mg (0.6000 mmol) tetrabromomethane, 187.3 mg (0.6000 mmol)
diphenyl diselenide, 13 µL (0.72 mmol) H2O and 61 µL (0.60 mmol) 50 in 12.0 mL CH3CN.
Irradiated for 12 days. Solvent was then removed in vacuo. Silica gel chromatography (silica
gel, gradient run from 20% EtOAc in hexanes to 100% EtOAc) afforded 76.6 mg (43%) of a
colorless oil. 1H NMR (400 MHz, CDCl3): δ 7.57 (m, 2H), 7.28 (m, 3H), 5.71 (d, J = 7.3 Hz),
3.82 (m, 1H), 3.03 (td, J = 11.2, 3.7 Hz, 1H), 2.14 (m, 2H), 1.91 (s, 3H), 1.67 (m, 2H), 1.52 (dq,
J = 12.2, 3.0 Hz, 1H), 1.27 (m, 3H); 13C NMR (62.5 MHz, CDCl3): δ 169.2, 135.3, 128.9, 128.2,
127.7, 53.1, 47.8, 40.0, 33.7, 26.6. 24.5, 23.3; HRMS m/z calcd for C14H20NOSe (M+H)+
292.0764, found 292.0746.
Synthesis of 53a and 53b:
Started with 199.0 mg (0.6000 mmol) tetrabromomethane, 187.3 mg (0.6000 mmol)
diphenyl diselenide and 74 µL (0.60 mmol) 52 in 12.0 mL CH3OH. Irradiated for 7 h. Solvent
was then removed in vacuo. Silica gel chromatography (silica gel, gradient run from 100%
hexanes to 10% ethyl acetate in hexanes) afforded 157.6 mg (97%) of a colorless oil. (*
indicates signals for minor isomer) 1H NMR (400 MHz, CDCl3) (mixture of regioisomers): δ
7.55* (m, 2H), 7.51 (dd, J = 1.7, 7.3 Hz, 2H), 7.22 (m, 3H), 3.51* (m, 2H), 3.35 (m, 1H), 3.32 (s,
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3H), 3.31* (s, 3H), 3.29* (m, 1H); 3.09 (dd, J = 12.2, 5.5 Hz, 1H), 2.99 (dd, J = 12.2, 6.1 Hz,
1H), 1.82* (m, 1H), 1.57 (m, 2H), 1.35 (m, 4H), 0.88 (m, 3H);

13

C NMR (100 MHz, CDCl3)

(mixture of regioisomers): δ 134.8*, 132.6, 130.8, 129.05, 128.95*, 127.5*, 126.8, 80.5, 75.9*,
58.70*, 56.95, 44.9*, 33.6, 31.99, 31.96*, 29.9*, 27.4, 22.77, 22.59*, 14.1, 14.0*; HRMS m/z
calcd for C12H17Se (M - OMe)+ 241.0490, found 241.0493.
Synthesis of 55:
Started with 199.0 mg (0.6000 mmol) tetrabromomethane, 187.3 mg (0.6000 mmol)
diphenyl diselenide and 73 µL (0.60 mmol) 54 in 12.0 mL CH3OH. Irradiated for 4 h. Solvent
was then removed in vacuo. Silica gel chromatography (silica gel, gradient run from 100%
hexanes to 10% ethyl acetate in hexanes) afforded 152.8 mg (99%) of a colorless oil. 1H NMR
(400 MHz, CDCl3) (1:1 mixture of diastereomers): δ 7.51 (m, 4H), 7.22 (m, 6H), 4.19 (m, 2H),
4.02 (m, 2H), 3.14 (dd, J = 12.1, 5.3 Hz, 2H), 2.96 (m, 2H), 2.05 (m, 4H), 1.67 (m, 2H), 1.47 (m,
2H), 1.23 (d, J = 6.0 Hz, 3H), 1.19 (d, 6.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) (1:1 mixture of
diastereomers): δ 132.5, 132.4, 130.5, 130.3, 129.0, 126.80, 126.76, 78.5, 77.9, 76.1, 75.4, 34.0,
33.5, 33.4, 33.0, 32.4, 31.5, 21.4, 21.3; HRMS m/z calcd for C12H17OSe (M+H)+ 257.0439,
found 257.0445.
Synthesis of 5620
Synthesis of 59:
To a round bottom flask containing 367.2 mg (3.030 mmol) 56 in 5 mL Et2O at 0°C was
added 4.6 mL (4.6 mmol) LiAlH4 (1.0 M in Et2O) dropwise. Reaction was allowed to stir under
N2 at room temperature for 5 h when complete conversion of starting nitrile was observed on
TLC. Reaction was once again cooled to 0°C. To the reaction mixture was added dropwise, in
succession, 7 mL Et2O, 0.18 mL deionized water, 0.18 mL 10 N NaOH, then 0.53 mL deionized
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water. The reaction was then allowed to stir at room temperature for 1.5 h to ensure complete
quenching of excess LiAlH4. The resulting aluminum salts were filtered off and the filter cake
was washed with Et2O. The filtrate was dried over Na2SO4, filtered and carefully concentrated
in vacuo to avoid loss of volatile amine product 57. The resulting amine 57 was added to a
round bottom flask containing 0.83 mL (6.0 mmol) Et3N in 10 mL CH2Cl2 at room temperature.
To this mixture was added 1.006 g (5.450 mmol) 58 in 15 mL CH2Cl2 at once. The reaction was
allowed to stir under N2 at room temperature for 2 h when amine 57 was completely consumed
as judged by TLC. To the reaction mixture was added 15 mL H2O and brought to a pH>11 with
the dropwise addition of 1M K2CO3. The aqueous layer was separated from the organic layer
and then extracted with 4x15mL CH2Cl2.

The resulting organic extracts were dried over

Na2SO4, filtered and concentrated in vacuo. Silica gel chromatography (silica gel, gradient run
from 70% CH2Cl2 in hexanes to 15% iPrOH in CH2Cl2) afforded 515.9 mg (62% over 2 steps) of
a colorless oil. 1H NMR (400 MHz, CDCl3): δ7.28 (m, 2H), 6.80 (d, J = 7.8 Hz, 1H), 6.17 (m,
1H), 6.01 (s, 2H), 5.71 (m, 1H), 5.58 (m, 1H), 3.49 (dt, J = 7.36, 5.72 Hz, 2H), 2.18 (m, 1H),
1.98 (m, 2H), 1.82 (m, 1H), 1.73 (m, 1H), 1.58 (m, 3H), 1.28 (m, 1H);

13

C NMR (100 MHz,

CDCl3): δ 166.9, 150.3, 148.1, 131.2, 129.2, 127.9, 121.5, 108.1, 107.8, 101.8, 38.1, 36.2, 33.2,
29.0, 25.4, 21.5; HRMS m/z calcd for C16H20NO3 (M+H)+ 274.1438, found 274.1440.
Synthesis of 60:
Started with 36.5 mg (0.110 mmol) tetrabromomethane, 34.3 mg (0.110 mmol) diphenyl
diselenide and 30.1 mg (0.110 mmol) 59 in 2.2 mL CH2Cl2. Irradiated for 2 days. Solvent was
then removed in vacuo. Silica gel chromatography (silica gel, gradient run from 100% hexanes
to 40% ethyl acetate in hexanes) afforded 33.4 mg (71%) of a pale yellow oil.

1

H NMR (400

MHz, CDCl3): δ 7.69 (m, 2H), 7.26 (m, 3H), 7.03 (d, J = 7.0 Hz, 1H), 6.99 (s, 1H), 6.79 (d, J =
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8.0 Hz, 1H), 5.99 (d, J = 1.4 Hz, 2H), 4.52 (m, 1 H), 3.70 (m, 2H), 3.37 (m, 1H), 2.43 (m, 1H),
1.98 (m, 1H), 1.84 (m, 2H), 1.56 (m, 5H); 13C NMR (100 MHz, CDCl3): δ 170.7, 149.1, 147.4,
134.5, 131.0, 129.5, 128.8, 127.1, 122.3, 108.5, 107.8, 101.2, 61.4, 48.0, 43.2, 37.1, 30.7, 28.1,
26.1, 21.3; HRMS m/z calcd for C22H24NO3Se (M+H)+ 430.0916, found 430.0902.
Synthesis of 61 and 62:
To a round bottom flask containing 13.2 mg (0.0306 mmol) selenide 60 in 1.57 mL
anhydrous toluene was added 16.7 µL (0.0621 mmol) Bu3SnH and 0.26 mg (0.0016 mmol – 0.13
mL taken from previously freeze-pump-thawed stock solution of 3.9 mg AIBN in 2mL
anhydrous toluene) AIBN. The reaction mixture was freeze-pump-thawed three times and
allowed to stir at reflux under N2. After 6, 24 and 32 h, 0.26 mg (0.0016 mmol – 0.13 mL taken
from previously mentioned degassed stock solution) AIBN was added. The reaction was stopped
after 48 h and concentrated in vacuo when complete consumption of starting selenide was
observed on TLC. Solvent was then removed in vacuo. Silica gel chromatography (silica gel,
gradient run from 100% hexanes to 40% EtOAc in hexanes) afforded 3.1 mg (37%) of a 1:1
mixture of regioisomers 61 and 62. 1H NMR data matched with spectrum kindly provided by S.
Z. Zard.21 HRMS m/z calcd for C16H18NO3 (M+H)+ 272.1281, found 272.1279.
Synthesis of 6422
Synthesis of 65:
To a solution containing 50.1 mg (0.210 mmol) carboxylic acid 64 in 2.0 mL 20%
DIPEA/ 80% DMF was added 32.2 mg (0.210 mmol) HOBt and 67.4 mg (0.210 mmol) TBTU at
once. The reaction was allowed to stir at room temperature for 30 mins. To the reaction mixture
was then added 26.3 mg (0.210 mmol) amine 57 in 1 mL 18% DIPEA/82% DMF dropwise. The
reaction was allowed to stir under N2 at room temperature for 5 h when complete conversion of
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starting materials were observed by 1H NMR of a reaction aliquot. To the reaction mixture was
added 5 mL H2O and 10 mL Et2O. The aqueous layer was separated from the organic layer and
then extracted with 4x10 mL Et2O. The resulting organic extracts were dried over Na2SO4,
filtered and concentrated in vacuo. Silica gel chromatography (silica gel, gradient run from 20%
CH2Cl2 in hexanes to 100% CH2Cl2 and 10% EtOAc in CH2Cl2 to 100% EtOAc) afforded 39.4
mg (54%) of a white solid. 1H NMR (400 MHz, CDCl3): δ 6.91 (d, J = 7.8 Hz, 1H), 6.73 (d, J =
7.8 Hz, 1H), 5.93 (s, 2H), 5.80 (m, 1H), 5.71 (m, 1H), 5.57 (m, 1H), 3.45 (dt, J = 7.3, 5.7 Hz,
2H), 2.19 (m, 1H), 1.99 (m, 2H), 1.83 (m, 1H), 1.62 (m, 4H), 1.28 (m, 1H) 0.33 (s, 9H);

13

C

NMR (100 MHz, CDCl3): δ 170.7, 153.3, 147.5, 136.9, 130.9, 127.8, 120.8, 118.7, 108.0, 100.3,
37.9, 35.9, 32.9, 28.8, 25.2, 21.3, 0.52; HRMS m/z calcd for C19H28NO3Si (M+H)+ 346.1833,
found 346.1832.
Synthesis of 66:
Started with 46.4 mg (0.140 mmol) tetrabromomethane, 43.7 mg (0.1400 mmol) diphenyl
diselenide, 34.9 mg (0.170 mmol) DTBMP and 48.7 mg (0.141 mmol) 65 in 4.0 mL CH2Cl2.
Irradiated for 3 days. Silica gel chromatography (silica gel, gradient run from 100% hexanes to
20% ethyl acetate in hexanes) afforded 59.8 mg (85%) of a yellow oil.

1

H NMR (400 MHz,

CDCl3): δ 7.65 (m, 2H), 7.25 (m, 3H), 6.73 (m, 2H), 5.923 (d, J = 12.2 Hz, 1H), 5.920 (d, J =
12.3 Hz, 1H), 4.43 (dd, J = 8.4, 6.1 Hz, 1H), 3.74 (td, J = 9.2, 3.5 Hz, 1H), 3.55 (m, 1H), 3.28
(m, 1H), 2.46 (m, 1H), 1.97 (m, 1H), 1.85 (m, 2H), 1.60 (m, 5H), 0.30 (s, 9H);

13

C NMR (100

MHz, CDCl3): δ 172.4, 153.0, 146.6, 136.7, 134.0, 130.0, 128.9, 126.9, 121.1, 117.6, 108.3,
100.2, 60.1, 48.4, 43.2, 37.2, 31.1, 27.7, 26.0, 21.6, 0.16; HRMS m/z calcd for C25H32NO3SeSi
(M+H)+ 502.1318, found 502.1313.
Synthesis of 67 and 68:
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To a round bottom flask containing 9.9 mg (0.020 mmol) selenide 66 in 5.5 mL benzene
was added 7.4 µL (0.024 mmol) TTMSS and 1.6 mg (0.0097 mmol) AIBN. The reaction
mixture was freeze-pump-thawed three times and allowed to stir at reflux under N2. After 5 h,
another 1.6 mg (0.0097 mmol) AIBN was added, and reaction mixture was once again freezepump-thawed three times and brought to reflux. The reaction was allowed to stir at reflux for an
additional 15 h and concentrated in vacuo when complete consumption of starting selenide was
observed on TLC. Silica gel chromatography (silica gel, gradient run from 100% hexanes to
10% EtOAc in hexanes) afforded 2.8 mg (41%) of 67 and 3.0 mg (44%) of 68.
Characterization for 67: 1H NMR (400 MHz, CDCl3) (mixture of rotamers): δ 6.76 (m,
2H), 6.71 (m, 2H), 5.94 (d, J = 2.0 Hz, 2H), 5.92 (d, J = 3.7 Hz, 2H), 4.18 (m, 1H), 3.63 (m, 2H),
3.49 (m, 1H), 3.40 (dt, J = 10.2, 2.5 Hz, 1H), 3.19 (m, 1H), 2.35 (m, 1H), 2.26 (m, 1H), 2.18 (m,
1H), 2.00 (m, 2H), 1.84 (m, 1H), 1.48 (m, 14H), 0.97 (m, 1H); 0.87 (m, 1H), 0.30 (s, 9H), 0.29
(s, 9H);

13

C NMR (125 MHz, CDCl3) (mixture of rotamers): δ 170.6, 170.1, 153.0, 152.9,

146.13, 146.07, 137.0, 136.4, 120.5, 120.4, 117.01, 116.99, 108.6, 108.4, 100.3, 100.2, 58.7,
56.1, 48.2, 44.5, 37.6, 36.6, 28.4, 27.5, 26.8, 26.2, 26.1, 25.3, 24.0, 23.5, 21.2, 20.1, -0.06, -0.25;
HRMS m/z calcd for C19H28NO3Si (M+H)+ 346.1833, found 346.1825.
Characterization for 68: 1H NMR (400 MHz, CDCl3): δ 6.63 (s, 1H), 5.938 (d, J = 10.5
Hz, 1H), 5.935 (d, J = 10.5 Hz, 1H), 3.88 (t, J = 4.7 Hz, 1H), 3.70 (m, 2H), 2.78 (dt, J = 12.1, 4.9
Hz, 1H), 2.32 (sextet, J = 5.6 Hz, 1H), 1.99 (m, 1H), 1.72 (m, 4H), 1.28 (m, 2H), 1.13 (m, 1H),
0.38 (s, 9H);

13

C NMR (125 MHz, CDCl3): δ 163.8, 152.8, 148.6, 138.9, 127.7, 120.5, 107.8,

100.2, 57.2, 43.1, 40.2, 38.1, 29.8, 29.4, 26.5, 23.8, 2.7; HRMS m/z calcd for C19H26NO3Si
(M+H)+ 344.1676, found 344.1679.
Synthesis of (±)-γ-lycorane:
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To a round bottom flask containing 21.7 mg (0.571 mmol) LiAlH4 and 1 mL previously
distilled THF under N2 at 0°C was added dropwise a solution of 9.8 mg (0.029 mmol) 68 in 3.5
mL previously distilled THF. The reaction mixture was allowed to stir at reflux for 19 h until
complete consumption of starting material was observed on TLC. Reaction was once again
cooled to 0°C. To the reaction mixture was added dropwise, in succession, 3 mL THF, 0.05 mL
deionized water, 0.05 mL 10N NaOH, then 0.1 mL deionized water. The reaction was then
allowed to stir at room temperature for 2 h to ensure complete quenching of excess LiAlH4. The
resulting aluminum salts were filtered off and the resulting filter cake was washed with THF.
The filtrate was dried over Na2SO4, filtered and carefully concentrated in vacuo to give 11.1 mg
of a 1:1 mixture of the desired product and the TMS-protected product. To this mixture was
added 1 mL DCM, 0.1 mL Et2O and 1 mL TFA. The reaction mixture was allowed to stir at
room temperature under N2 for 6 h at which point the mixture was concentrated in vacuo. To the
concentrated reaction mixture was added enough iPrOH to dissolve the crude material. 10M
NaOH was then added until the reaction reached a pH =12. To this basic mixture was added 5
mL 20% iPrOH/ 80% DCM. The aqueous layer was separated from the organic layer and then
extracted with 4x5 mL 20% iPrOH/ 80% DCM. The resulting organic extracts were dried over
Na2SO4, filtered and concentrated in vacuo. Unfortunately, the crude 1H NMR demonstrated that
the amine had been reprotonated by small amounts of HCl present in the CDCl3. Therefore, the
concentrated reaction mixture needed to be re-basified and was added enough iPrOH to dissolve
the crude material. 10M NaOH was then added until the reaction reached a pH =13. To this
basic mixture was added 5 mL 20% iPrOH/ 80% DCM. The aqueous layer was separated from
the organic layer and then extracted with 4x5 mL 20% iPrOH/ 80% DCM. The resulting organic
extracts were dried over Na2SO4, filtered and concentrated in vacuo. Silica gel chromatography
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in a pipet column (silica gel, gradient run from 100% hexanes to 100% EtOAc) afforded 5.0 mg
(68% over 2 steps) of (+/-)-γ-lycorane as a white powder. 1H NMR (400 MHz, CDCl3): δ 6.61
(s, 1H), 6.49 (s, 1H), 5.89 (m, 2H), 4.02 (d, J = 14.4 Hz, 1H), 3.38 (m, 1H), 3.22 (d, J = 14.2 Hz,
1H), 2.74 (dt, J = 12.1, 4.6 Hz, 1H), 2.38 (m, 1H), 2.18 (m, 2H), 2.02 (m, 1H), 1.71 (m, 3H),
1.47 (m, 2H) 1.30 (m, 2H);

13

C NMR (500 MHz, CDCl3): δ 146.1, 145.7, 133.2, 127.3, 108.3,

106.3, 100.7, 62.9, 57.1, 53.7, 39.5, 37.4, 31.7, 30.4, 29.3, 25.2; HRMS m/z calcd for C16H20NO2
(M+H)+ 258.1489, found 258.1489.
Synthesis of 69:
Started with 199.0 mg (0.6000 mmol) tetrabromomethane, 245.6 mg (0.6000 mmol)
diphenyl ditelluride and 62 µL (0.60 mmol) 40 in 12.0 mL CH2Cl2. Irradiated for 47 h. Solvent
was then removed in vacuo. Silica gel chromatography (silica gel, gradient run from 100%
hexanes to 10% ethyl acetate in hexanes) afforded 203.3 mg (75%) of a pale yellow solid. 1H
NMR (400 MHz, CDCl3): δ 8.11 (m, 2H), 7.49 (m, 3H), 4.91 (m, 1H), 4.18 (m, 1H), 4.07 (m,
2H), 3.85 (m, 1H), 2.15 (m, 3H), 1.81 (m, 1H);

13

C NMR (100 MHz, CDCl3): δ 134.6, 131.6,

130.2, 128.7, 73.5, 69.5, 59.3, 32.3, 26.4.
Synthesis of 70:
Started with 199.0 mg (0.6000 mmol) tetrabromomethane, 245.6 mg (0.6000 mmol)
diphenyl ditelluride and 72 µL (0.60 mmol) 38 in 12.0 mL CH2Cl2. Irradiated for 44 h. Solvent
was then removed in vacuo. Silica gel chromatography afforded (silica gel, gradient run from
100% hexanes to 60% ethyl acetate in hexanes) 147.8 mg (53%) of a pale orange solid. 1H NMR
(400 MHz, CDCl3): δ 8.09 (m, 2H), 7.47 (m, 3H), 4.24 (m, 1H), 4.11 (m, 1H), 4.00 (m, 2H), 3.56
(dt, J = 11.5, 2.0 Hz, 1H), 1.94 (m, 1H), 1.80 (m, 1H), 1.58 (m, 4H);
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13

C NMR (100 MHz,

CDCl3): δ 134.5, 131.3, 129.9, 128.9, 72.6, 69.6, 57.0, 32.1, 25.1, 22.9; HRMS m/z calcd for
C12H16BrOTe (M-Br)+ 384.9441, found 384.9415.
3.4.4 Computational Methods
DFT calculations were performed using Gaussian 09 C.01 64-bit version.23 The hybrid
B3LYP functional and 6-311G** basis set were employed to optimize all structures and to obtain
the thermochemical data. PhSe•, CBr4, PhSeBr and •CBr3 were optimized in the absence of
solvents (in a vacuum). The calculated thermodynamic values for the following process are
shown in Figure S3:
PhSe• + CBr4 → PhSeBr + •CBr3
These structures were optimized in the presence of three solvents (CH2Cl2, MeOH,
CH3CN). All of the structures were optimized using the 6-311G** basis set. The Polarizable
Continuum Model (PCM) using the integral equation formalism variant (IEFPCM) was
employed to perform calculations in the presence of solvents.
Table 3.4 Gaussian 2009 calculated enthalpies, entropies, and Gibbs free energies
ΔHrxn
(kcal/mol)

ΔSrxn (kcal/mol)

ΔGrxn (kcal/mol)
@ 298 K

No solvent model

-8.369

0.0029

-9.25

CH2Cl2 model

-8.384

0.0029

-9.25

CH3OH model

-8.336

0.0028

-9.17

CH3C≡N model

-8.333

0.0028

-9.17
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3.4.5 Crystal Structures

Figure 3.5 Crystal structure of telluride 69

Figure 3.6 Crystal structure of 71
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CHAPTER 4: DEVELOPMENT OF VISIBLE LIGHT PHOTOCATALYTIC METHOD
FOR ORGANIC THIN FILM FORMATION ON GOLD USING ARYL IODIDES
4.1

Introduction

4.1.1 History and Significance of Organic Thin Films
Organic thin films play an important role in everyday life. Knowledge and utilization of
organic thin films has existed for over millennia. Circa 1800 BC in Babylonia and Assyria, a
form of divination involved pouring hydrocarbon-based oils on water and interpreting a person’s
future based on the way the oil would spread over the water surface and against the container. 1
In the early 1st century CE, Roman philosopher Pliny the Elder observed that divers would often
pour oil onto a body of water in order to make the water clearer and easier to see to the bottom,
where the desired objects, like clams or oysters, would be.2

Benjamin Franklin ran an

experiment which consisted of pouring a teaspoon of oil onto a pond. The oil spread out over the
entire pond and made the water so that it appeared “as smooth as a looking-glass.” To explain
this phenomenon, Lord Rayleigh theorized that oil would spread until it was one molecule thick,
thus forming a monolayer.3
Over forty years later, a major breakthrough in thin film technology was accomplished by
Irving Langmuir and Katharine Blodgett when they realized that organic multilayers could be
synthesized by repeatedly submerging glass plates into a solution of calcium stearate in polar
solvents.4 They found that the carboxylate head groups of the stearate moiety would attach to
glass surface forming the thin layer. Repeated dipping of the glass substrate into the calcium
stearate solution could produce multilayers up to 200 multilayers thick.

These films had

applications as antireflection coatings.
Today, organic thin films are used in a wide variety of applications like biosensors,
coatings for medical devices, anti-corrosion resists, and organic thin film transistors.5 Organic
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thin films provide a barrier between solid matter and a liquid or gaseous phase. Thin films also
provide an opportunity to functionalize a solid surface, where thickness and functionality can be
controlled to synthesize designer interfaces.
4.1.2 Methods for Thin Film Formation
The most popular method for thin film formation is via the grafting of thiol precursors to
metals like gold and platinum. Thin film formation prior to the 1980’s consisted of attaching a
molecule with a polar functional group to a surface, as described in the previous section.
Although these films provided an important step in materials research, they were often weakly
bound to the surface and were structurally uninteresting. Any functional group that would be of
any use was bound to the surface and unable to undergo further reaction. The only part of the
layer that was available was usually an unreactive hydrocarbon chain.
In search of a method to functionalize surfaces with coatings containing interesting
terminal groups, organic chemists Ralph Nuzzo and David Allara performed research on the
formation of thin films from thiol precursors. They found that monolayers of thiol-containing
compounds were spontaneously formed when gold was submerged in a thiol solution.6 Sulfur
has a strong affinity for metal surfaces, and thiols outcompete carboxylates or other functional
groups from grafting onto metals.5f Therefore, molecules to be attached to a gold surface can
have pendant functional groups that will be on the outer surface of the layer and available for
further reaction.

Relatively homogenous mixed thiol monolayers can also be easily made

through the immersion of a gold plate in a solution of two or more thiols.7 Since Nuzzo and
Allara’s discovery, thiol self-assembled monolayers have become integral parts of
nanotechnology research. However, these thiol self-assembled mmonolayers suffer from several
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drawbacks. They are relatively unstable toward oxidation and thermal desorption. For example,
dodecanethiol monolayers undergo desorption at 100C and are unstable to oxidation.5e, 8
As a way to produce more stable thin films, other methods for synthesizing organic thin
films were explored. The most notable method was developed initially in the 1990’s. This
method entailed the grafting of aryl radicals, generated in situ via the UV irradiation or cathodic
reduction of diazonium salts, onto carbon materials to form multilayers. 5a These synthesized
layers overcame problems presented by thiol-derived thin films. For instance, the films were
considerably more stable, with no thermal desorption occurring up to a temperature of 427C on
glassy carbon.5c

These multilayers were also relatively stable to oxidation, being able to

withstand storage in air for several months. The same multilayers were not removed or degraded
by sonication and boiling solvents. The stability of the formed multilayers stems from the
strength of the covalent bonding of carbon, on the arene ring, and the metal or carbon surface.
The presence of the covalent bond between the organic substrate and a gold surface has been
demonstrated by both X-ray photoelectron spectroscopy (XPS)9 and high resolution electron
energy loss spectroscopy (HREELS).10 The covalent gold-carbon bond strength was determined
to be ~30 kcal/mole by Scherlis and coworkers using computational methods.10 This bond is,
therefore, similar in strength to that in I2.
As previously mentioned, the original method for generation of aryl radicals from
diazonium salts involved either the irradiation by UV light or the cathodic reduction of
arendiazonium salts to generate aryl radicals that graft to surfaces. Both of these methods,
however, require advanced and expensive experimental setups. In an effort to improve the ease
of grafting of aryl radicals, generated from diazonium salts, a visible light-promoted method was
developed.11 In this photocatalytic method, blue LED irradiation coupled with the photocatalyst,
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Ru(bpy)32+, generated aryl radicals from diazonium salts. The initiation step in the process was
the promotion of the catalyst to its excited state, [Ru(bpy)32+]*, by the absorption of a photon
from a visible light source (Scheme 4.1). After undergoing intersystem crossing to the triplet
state, the excited state photocatalyst donates an electron to the diazonium salt 72, which loses N2
to generate the aryl radical 73. The aryl radical 73 can then attach to the Au surface to form a
covalent gold-carbon bond 74. Polymerization, and thus multilayer formation, occurs when
another aryl radical intercepts the arene already grafted to the surface. Regeneration of the
photocatalyst is then accomplished via oxidation of the dimer radical 75 to form the cation,
which then quickly rearomatizes to the desired grafted product. The thickness of the multilayers
can be modified by varying the irradiation time. The longer the irradiation time is, the thicker
the polymer thin film 77 will be.11a
hmax=452 nm
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Scheme 4.1 Photografting of arenediazonium salts11b
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Although the multilayers formed via visible light photografting of arenes are stable to
oxidation and thermal desorption due to the strength of the gold-carbon covalent bond, the
method has several limitations. For instance, diazonium salts are themselves relatively unstable.
Because diazonium salts undergo decomposition within days, even under N2 at -20C, they
cannot be stored for long periods of time. The diazonium moiety is also extremely polar and
sensitive to acidic conditions. Traditional purification methods by chromatography, therefore,
are difficult and present many problems. Another method for generation of aryl radicals for
grafting onto surfaces would be beneficial.
4.1.3 Photocatalytic Generation of Aryl Radicals from Aryl Iodides
Electrografting of aryl iodides is not possible. This is due to the overreduction of the aryl
iodide to the aryl carbanion instead of the desired aryl radical at potentials low enough to convert
aryl iodide to aryl radical.12 However, recent research has been performed demonstrating the
generation of aryl radicals from aryl iodides using visible light photocatalysis.13 Stephenson and
coworkers used the photocatalyst Ir(ppy)3 (Figure 4.1) to accomplish the generation of aryl
radicals. Aryl iodides have a reduction potential ranging from -1.6V to -2.2V vs. SCE. Ir(ppy)3*
has a reduction potential of -1.73V (versus SCE), making it an ideal candidate for single-electron
transfer (SET) to and reduction of aryl iodides.
PF6
tBu
N

N
N

Ir

Ir
N

N

N
N

Ir(ppy)3

tBu

[Ir(ppy)2(dtbbpy)][PF6]

Figure 4.1 Iridium catalysts
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In Stephenson’s work, several aryl iodides underwent transformation to the
corresponding arene via the intermediacy of an aryl radical (Scheme 4.2). The photocatalyst
Ir(ppy)3, upon irradiation by visible light, was brought to its excited state Ir(ppy)3*. This excited
state photocatalyst was then able to reduce the aryl iodide to the aryl radical, with the leaving of
iodide. The aryl radical was then able to abstract a hydrogen atom from tributylamine radical
cation, Hantzsch ester or formic acid. The photocatalyst was regenerated by the one electron
oxidation of either tributylamine or the Hantzsch ester (Scheme 4.2). The substrate scope for
this transformation was broad, with yields ranging from 92-98%. Evidence that the reaction was
occurring via the oxidative quenching cycle was found in a control experiment when the reaction
proceeded without the Hantzsh ester, formic acid or tributylamine, albeit at a lower percent yield.
Electron donor
Oxidized electron
donor
Ir(ppy)3
Ar-I

fac-Ir(ppy)3, Bu3N, MeCN, h

h
Ir(ppy)3

Hantzsch ester
-orHCO2H

Ar-H

Hantszsh ester

Ir(ppy)3*

Hydrogen
Ar abstraction Ar-H

EtO2C

CO2Et
N
H

Ar-I

Scheme 4.2 Proposed mechanism for aryl radical generation under the Stephenson conditions13a
Kim and Lee also developed a photocatalytic method for aryl radical formation from aryl
radical precursors.13b

In Lee’s method, the photocatalyst used was [Ir(ppy)2(dtbbpy)][PF6],

having a reduction potential of -1.51V (versus SCE) in the excited state (Figure 4.1). Both
Ir(ppy)3 and [Ir(ppy)2(dtbbpy)][PF6] have metal-to-ligand-charge-transfer (MLCT) bands at 40087

500 nm, making them susceptible to excitation by blue LEDs (max=455nm). In the mechanism
for the conversion of aryl iodide to the hydrogen abstraction product under Lee’s conditions, the
iridium catalyst is first excited by visible light (Scheme 4.3). The excited state photocatalyst is
then reduced by diisopropylethylamine (DIPEA) to the iridium (II) species. It is then able to
undergo a single electron transfer (SET) to the aryl iodide, which loses iodide anion to give the
aryl radical, regenerating the iridium catalyst in the process. This aryl radical can then cyclize
onto any present pendant alkenes. In the termination step of the mechanism, the radical abstracts
a hydrogen atom from the previously oxidized DIPEA to give the desired product. Yields under
Lee’s conditions were also excellent, ranging from 82-96%.
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Scheme 4.3 Proposed mechanism for aryl radical generation under the Lee conditions13b
4.1.4 Brief Overview of Atomic Force Microscopy
Our primary method for surface analysis in this section is atomic force microscopy
(AFM).

Since its introduction in the 1980’s, AFM has been indispensable as tool for

characterizing thin films on a variety of surfaces.14 In general for a topographical image, the
AFM gathers information from a sample by scanning the surface with a silicon or Si3N4
cantilever (Figure 4.2). This information can be used to create an image. As the cantilever is
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scanned over the surface of a sample, the tip is displaced upward or downward as a function of
constant force between the tip and the sample. This movement is measured by a laser diode
which reflects off the top of the cantilever to be collected by a detector consisting of two
photodiodes. As the angular displacement of the laser changes, the amount of light that is
collected by one of the diodes will be greater than the other. This produces an output signal
which can be translated into depth analysis of the surface.

Figure 4.2 Basic experimental setup for AFM
In addition to providing an image of a surface, AFM coupled with particle lithography
can be implemented to measure the depth of a thin film. Particle lithography often involves the
addition of silica mesospheres to a clean surface before grafting of any organic thin film. Upon
formation of the thin film, the mesospheres effectively mask the surface at the areas of contact
while the thin film forms around them (Figure 4.3).

After formation of the films, the

mesospheres are removed via sonication in ethanol. Where the silica mesospheres were once
located, nanopores are formed. The depth of the organic layer can then be measured by scanning
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the AFM cantilever over the nanopores and measuring the distance between the substrate and the
top of the thin films as a function of constant force.

Figure 4.3 Immersion particle lithography11a
4.2

Results and Discussion
In order to provide a way to better synthesize thin layers of arenes on gold surfaces

without suffering the limitations of electrografting or photografting of diazonium salts, aryl
radicals generated from aryl iodides were grafted to atomically flat Au(111) surfaces via visible
light photocatalysis. The resulting films were then characterized by AFM, water contact angle
measurements and X-ray photoelectron spectroscopy (XPS).
4-Iodoanisole was chosen as the first molecule to be grafted, initially using Stephenson’s
conditions (Scheme 4.2).

The hypothesis was that 4-anisyl radicals, formed from the

photocatalyic reduction of 4-iodoanisole, would graft to the surface forming a covalent goldcarbon bond. To accomplish this goal, 4-iodoanisole was placed into an Erlenmeyer flask with
Ir(ppy)3, Hantzsch ester, tributylamine and MeCN in the presence of a gold substrate
accompanied by vigorous stirring and irradiated with blue LEDs for 18.5 hours. Formic acid
was not used as a hydrogen donor due to the possible removal of the mesospheres under acidic
conditions. Aliquots of the solution were analyzed by 1H NMR over time, and 4-iodoanisole was
completely converted to anisole after 18.5 hours. After irradiation, the template-stripped-gold
(111) (TSG)15 substrates with 500 nm mesospheres deposited via immersion particle lithography
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were analyzed with AFM. The initial images illustrated the formation of thin films of ~2 nm in
thickness (Figure 4.4). However, after multiple experiments at varying concentrations, uniform
and consistent grafting of anisole onto the gold surface proved to be unreliable with grafting
occurring only on patches of the gold if at all. The initial results were not reproducible.

Figure 4.4 AFM images of 4-anisyl on gold using Stephenson’s conditions
With the possibility that the formed aryl radical was simply abstracting a hydrogen atom
from either the Hantzsch ester or the tributylamine before being able to reach the gold surface,
another route towards the synthesis of an anisole thin film was deemed necessary.
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Lee’s

conditions for the generation of aryl radicals from aryl iodides were then attempted (Scheme
4.3).
Before

photografting

under

Lee’s

conditions

could

be

accomplished,

[Ir(ppy)2(dtbbpy)][PF6] was synthesized (Scheme 4.4). Phenylpyridine 86 was first reacted with
irdium (III) chloride hydrate in 2-ethoxyethanol to give the bimetallic species 87 in 67% yield.
The bimetallic intermediate 87 then underwent a ligand exchange with 4,4’-di-tert-butyl-2,2’bipyridyl in ethylene glycol with ammonium hexafluorophosphate to produce the desired
photocatalyst in 69% yield.

N

N
IrCl3.H2O
N

Ir

2-ethoxyethanol
67%

N

Cl
Cl

Ir
N

86
87
PF6
tBu

N

N
tBu

But

N
Ir

N

N

NH4PF6, ethylene glycol
69%

N

tBu

[Ir(ppy)2(dtbbpy)][PF6]

Scheme 4.4 Synthesis of [Ir(dtbbpy)(ppy)2][PF6]
For thin film synthesis under Lee’s conditions, 4-iodoanisole at an initial concentration of
0.01 M was placed in an Erlenmeyer flask with [Ir(dtbbpy)(ppy)2][PF6], DIPEA and MeCN in
the presence of TSG AFM gold plates15 and irradiated for 18.5 hours. After removal of the silica
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mesospheres by sonication in ethanol, AFM images illustrated that a uniform thin film was
formed, but only at a thickness of ~1 nm (Figure 4.5).

Figure 4.5 AFM image of 4-anisyl on gold using Lee’s conditions with a 4-iodoanisole
concentration of 0.01 M
Because thicker films are often useful for further analysis by infrared reflectionabsorption spectroscopy (IRRAS) and XPS, the concentration of 4-iodoanisole was increased to
0.1M. Upon irradiation at this concentration and subsequent removal of the mesospheres, the
depth of the formed nanopores was determined to be 2 nm by AFM (Figure 4.6). To further
increase the anisole layer thickness, the 4-iodoanisole concentration was increased to 0.3 M and
irradiated for 18.5 hours. The resulting film, however, was demonstrated by AFM to be not
uniform in thickness across the entire surface, varying from 1-4 nm in depth.

The most

consistent and homogenous result, therefore, was obtained by using the 4-iodoanisole
concentration of 0.1 M. To demonstrate that the thin film seen on AFM was not a result of
grafting of DIPEA or MeCN, a control experiment was run where only [Ir(dtbbpy)(ppy)2][PF6],
DIPEA and MeCN was irradiated with the Au(111) substrate. No film was present on AFM.
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Figure 4.6 AFM image of 4-anisyl on gold using a 4-iodoanisole concentration of 0.1 M
In order to determine the elemental analysis of the surface, XPS was necessary. First,
large Au(111) slides were bought and cleaned via UV irradiation over 6 hours. Water contact
angles were determined to be 62 ± 2. This corresponded to the literature value for contact
angle measurement of 57 ± 4of a bare gold surface.11b This slide was then irradiated under the
favorable conditions (0.1 M 4-iodoanisole concentration). After irradiation, the water contact
angle was measured to be 75 ± 2. The increase in water contact angle illustrates that the gold
surface is more hydrophobic(Figure 4.7).

Figure 4.7 Water contact angles of gold plate before and after grafting of anisole
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Figure 4.8 XPS spectrum of anisole thin film on gold plate
XPS data collected from the gold slide after irradiation confirmed the formation of
anisole thin films on the surface (Figure 4.8). The elements detected were Au(4f 7/2, 4d5/2, 4d3/2),
C1s and O1s with no indication of the presence of nitrogen, demonstrating that DIPEA had not
grafted. The notation after the element symbol corresponds to the orbital in which the electrons
are excited. The observed binding energies for carbon and oxygen were 285.0 eV and 532.3 eV,
respectively. The binding energy for oxygen is close to that of anisole O1s presented in the
literature, suggesting the presence of an anisole thin film on the gold surface.16
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4.3

Future Work
In order to increase the substrate scope for this developed method, many other aryl

iodides will be used (Figure 4.9). The aryl iodides will first only vary in terminal functionality.
For example, the methoxy group in 4-iodoanisole will be replaced by a nitrile, protected amine,
methyl group or bromine.

This will demonstrate that the developed method is applicable

towards a large variety of functional groups. More complex structures will also be attempted to
show that specially designed thin films are possible and can be synthesized with only one
grafting procedure instead of two or more.

Infrared Reflection-Absorption Spectroscopy

(IRRAS) will also be used for all synthesized thin films to better characterize the multilayers
present on the gold surface. This technique will provide IR data of the thin film.
HO2C
H
N

O

R

CO2H
N
4

I
R = CH3, CN, Br, etc.

CO2H

I

Figure 4.9 Proposed substrate scope
Monolayer formation via the use of removable protecting groups will also be explored.
Currently, multilayers are formed due to the attack of additional aryl radicals onto the meta
position of the already formed anisole monolayer (Scheme 4.1). The multilayers attack at the
meta position, because the para position is already functionalized and the ortho position is too
sterically hindered. To prevent this attack from occurring, substrates will be made containing
removable protecting groups, like a doubly Boc-protected amine (Scheme 4.5). The protected
amine would first be grafted under the developed conditions. The Boc groups would sterically
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prevent any further polymerization during irradiation. Once grafting is complete, the protecting
groups will be removed to reveal a monolayer.
N(Boc)2

N(Boc)2

N(Boc)2

NH2

Deprotection

Photografting

Surface

Surface

I

NH2

Scheme 4.5 Monolayers resulting from removable blocking groups
4.4

Conclusions
Organic thin films play an integral role in nanoscience and surface science. In general,

these films are generated from the immersion grafting of thiols onto metal surfaces.

The

synthesized thiol monolayers, however, are unstable to oxidation and are susceptible to thermal
desorption, even at relatively low temperatures under inert atmosphere. One way of providing
more stable thin films is the grafting of aryl radicals generated from diazonium salts. The
resulting carbon-gold bond is extremely stable towards oxidation and high temperatures. The
methods used to generate these aryl radicals from diazonium salts often require complex
experimental setups, and the diazonium salts cannot withstand multistep synthesis. To overcome
these issues, a visible light photocatalytic method of grafting aryl radicals, generated from aryl
iodides, onto gold surfaces was developed. AFM confirmed the presence of an anisole thin film,
ranging from 1-4 nm, and XPS spectra indicated that carbon and oxygen were on the surface.
This method will be applied to many other aryl iodides in the future.
4.5

Experimental

4.5.1 General Methods
Gold slides were obtained from Evaporated Metal Films (Product # CA134). They
consist of a glass slide coated with a 50 Å chromium binder layer followed by a 1,000 Å gold
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layer. 4-Iodoanisole, [Ir(dtbbpy)(ppy)2][PF6], and absolute ethanol were obtained from SigmaAldrich, and the corresponding catalog numbers were 17608, 688096, and 459844.
Diisopropylethylamine was obtained from Acros Organics, and the catalog number was
367840010.

These chemicals were used without purification. Acetonitrile was purified

according to the method of Grubbs.17
4.5.2 Synthesis of [Ir(dtbbpy)(ppy)2][PF6]
Synthesis of [Ir(dtbbpy)(ppy)2][PF6] was accomplished according to the procedures of
Polosan18 and Lowry19.
4.5.3 Procedure for Immersion Particle Lithography
Two types of substrates were used for preparing samples. Ultraflat gold films were
prepared on mica(0001) by evaporative deposition. Template-stripped, gold substrates were
prepared by a previously reported procedure.15 Glass discs were glued to freshly prepared gold
films using an epoxy (EPO-TEK, Billerica, MA). Pieces of ultraflat gold/glass were stripped
from mica to expose a clean, atomically flat Au(111) surface. Size-sorted silica mesospheres
with an average diameter of 500 nm (Thermo Scientific) were cleaned by centrifugation and
suspension in water (three cleaning cycles). A 40 μL drop of the silica mesosphere suspension
was placed onto the template-stripped gold substrates, dried in air for 2 h, and then oven-dried at
150 °C for at least 14 h. The final heating step was used to temporarily anneal the silica spheres
to the substrate to prevent displacement during immersion in solutions. After completion of the
chemical reactions, removal of the surface mask was accomplished by sonication in clean
solvents.
4.5.4 Cleaning of Large Au (111) Slides
The gold plates, once obtained from Evaporated Metal Films, were placed in a triangular
prism-shaped box made from cardboard (see below) with a UV penlight attachment. The plates
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were then irradiated for 24 h in the presence of O2 and transferred immediately to a reaction
vessel for use in experiments. The water contact angle was 62° for freshly-irradiated Au (111)
plates.

Figure 4.10 Apparatus for cleaning of gold slides
4.5.5 Experimental Setup

Figure 4.11 Photografting experimental setup
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4.5.6 Photografting Procedure for AFM TSG Au Plates
The Au (111) plate was placed gold side up on one side of a 60 mL Erlenmeyer flask. A
flea stir bar was placed in the Erlenmeyer flask on the opposite side so that the stir bar did not
disturb the gold surface. For the samples run at a concentration of 0.01 M, the flask was then
charged with 1.9 mg (0.0021 mmol) [Ir(dtbbpy)(ppy)2][PF6] and 16.4 mg (0.0700 mmol) 4iodoanisole. A septum was then placed over the top of the flask and 0.12 mL (0.70 mmol)
DIPEA and 6.9 mL MeCN was added at once via syringe. The reaction was then placed in an
evaporating dish surrounded by blue LEDs (see Experimental Setup) and allowed to stir under
N2 for 18.5 h (sparging not necessary). The gold plate was then carefully removed from the
Erlenmeyer flask and rinsed first with 5 mL DI H2O and then 5 mL absolute EtOH before setting
on a paper towel to air dry. The samples were sonicated in EtOH for 1 min to remove the
mesospheres and any remaining non-covalently bound residues. [Note: Photografting procedure
for concentration of 0.1M was the same as above except the following amounts of reagents were
used: 19.2 mg (0.0210 mmol) [Ir(dtbbpy)(ppy)2][PF6], 163.8 mg (0.7000 mmol) 4-iodoanisole,
1.22 mL DIPEA and 5.78 mL MeCN.]
4.5.7 Photografting Procedure for XPS Large Au Slides (0.1 M)
A 125 mL Erlenmeyer flask was charged with 57.6 mg (0.0630 mmol)
[Ir(dtbbpy)(ppy)2][PF6] and 491.4 mg (2.100 mmol) 4-iodoanisole. The Au (111) plate was then
placed gold side up on one side of the flask. A stir bar was placed in the Erlenmeyer flask on the
opposite side of the flask so that the stir bar did not disturb the gold surface. A septum was then
placed over the top of the flask and 3.66 mL DIPEA and 17.34 mL MeCN was added at once via
syringe. The reaction was then placed in an evaporating dish surrounded by blue LEDs (see
Experimental Setup) and allowed to stir under N2 for 18.5 hr (sparging not necessary). The gold
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plate was then carefully removed from the Erlenmeyer flask and rinsed first with 5 mL DI H2O
and then 5 mL absolute EtOH. The plate was then submerged in EtOH and sonicated for 5
minutes. After sonication, the plate was again rinsed first with 5 mL DI H2O and then 5 mL
absolute EtOH before setting on a paper towel to air dry.
4.5.8 Water Contact Angle Measurements on Large Au Slides
Water contact angle measurements were obtained using a VCA Optima XE instrument.
Two microliters of DI water were dropped onto the horizontal gold surface per measurement. At
least six measurements were taken per sample in order to obtain a reliable value. The contact
angle was calculated using the Sessile Drop method on AutoFAST Imaging software.
4.5.9 X-ray Photoelectron Spectroscopy (XPS)
Surface elemental analyses of the Au plates were performed using a Kratos Axis Ultra Xray photoelectron spectroscopy system.

The surface analysis chamber was equipped with

aluminum Kα X-ray gun and a 500 mm Rowland circle silicon single-crystal monochromator.
The X-ray gun was operated using a 15 mA emission current at an accelerating voltage of 15 kV.
Low-energy electrons were used for sample charge compensation. High-resolution spectra were
acquired in the region of interest using the following experimental parameters: 20–40 eV energy
window, pass energy of 20 eV, step size of 0.1 eV, and dwell time of 1000 ms. One sweep was
used to acquire a survey spectrum of all binding regions (1200–0 eV) at a pass energy 160 eV,
step size of 1 eV, and a dwell time of 100 ms. Samples were mounted by pressing them to
indium foil for analysis. All spectra were calibrated using the adventitious Au4f peak at 84.0 eV.
A Shirley-type background was subtracted from each spectrum to account for inelastically
scattered electrons contributing to the broad background.

101

4.5.10 Atomic Force Microscopy (AFM)
The samples were imaged using a model 5500 or model 5420 atomic force microscope
with Pico View v.1.12 software (Agilent Technologies, Chandler, AZ). Non-conductive imaging
probes from Bruker (MSCT, 0.01–0.6 N/m) were used to acquire contact-mode images. Images
were processed and analyzed using Gwyddion (v. 2.22), an open-access processing software
designed for AFM images, supported by the Czech Metrology Institute.20
4.6
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APPENDIX B: NMR SPECTRA OF COUMPOUNDS FOUND IN CHAPTER 1
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APPENDIX C: NMR SPECTRA OF COUMPOUNDS FOUND IN CHAPTER 2
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APPENDIX D: NMR SPECTRA OF COUMPOUNDS FOUND IN CHAPTER 3
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